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Pyrrolidine-amide oligonucleotide mimics (POM) 1 were designed to be stereochemically and conformationally
similar to natural nucleic acids, but with an oppositely charged, cationic backbone. Molecular modelling reveals
that the lowest energy conformation of a thymidyl-POM monomer is similar to the conformation adopted by
ribonucleosides. An eﬃcient solution phase synthesis of the thymidyl POM oligomers has been developed, using
both N-alkylation and acylation coupling strategies. 1H NMR spectroscopy conﬁrmed that the highly water soluble
thymidyl-dimer, T2-POM, preferentially adopts both a conﬁguration about the pyrrolidine N-atom and an overall
conformation in D2O that are very similar to a typical C3-endo nucleotide in RNA. In addition the nucleic acid
hybridisation properties of a thymidyl-pentamer, T5-POM, with an N-terminal phthalimide group were evaluated
using both UV spectroscopy and surface plasmon resonance (SPR). It was found that T5-POM exhibits very high
aﬃnity for complementary ssDNA and RNA, similar to that of a T5-PNA oligomer. SPR experiments also showed
that T5-POM binds with high sequence ﬁdelity to ssDNA under near physiological conditions. In addition, it was
found possible to attenuate the binding aﬃnity of T5-POM to ssDNA and RNA by varying both the ionic strength
and pH. However, the most striking feature exhibited by T5-POM is an unprecedented kinetic binding selectivity for
ssRNA over DNA.
Introduction
Modiﬁed nucleic acids and oligonucleotide mimics are of con-
siderable interest as agents for down-regulating gene expression
through hybridisation either with target mRNA (antisense) or
dsDNA (antigene).1–6 This approach has not only led to new
therapeutic treatments, but is widely used in target validation to
identify new therapeutic targets. In addition, modiﬁed oligo-
nucleotides are of value as diagnostic and bio-analytical probes,
or as tools in molecular biology.6–11 These molecules are also of
fundamental importance as models to explore the structure–
function relationship of nucleic acids.12,13 In particular, by
studying the biophysical properties of chemically modiﬁed
nucleic acids, it is argued that we can gain insight as to why
DNA and RNA were selected as the ubiquitous genetic
materials on this planet.14
Despite the large number of backbone modiﬁcations that
have been developed, surprisingly few confer enhanced recog-
nition properties, aﬃnity and sequence selectivity, for DNA and
RNA relative to native nucleic acids.1,15 A general strategy to
enhance aﬃnity has been to develop modiﬁed oligonucleotides
that are better pre-organised by restricting the conformational
freedom of the backbone.1,16 For example, sugar modiﬁcations
which retain the native phosphodiester linkage, such as LNA
2 (Fig. 1),17,18 have been used to particularly good eﬀect.5,6,11
Several groups have also replaced the phosphodiester linkage in
nucleic acids with alternative neutral linkages based on the
premise of favourable enthalpy changes resulting from dimin-
ished electrostatic repulsion between strands.1 However even
† Electronic supplementary information (ESI) available: experimental
details (16 Figures, 3 Tables). See http://www.rsc.org/suppdata/ob/b3/
b306156f/
the best of all neutral linkages, for example amide 3 19 or 3-N-
sulfamate modiﬁed DNA,20 result in only modest increases in
aﬃnity for complementary nucleic acids. Of all the neutral
mimics that have been developed, probably PNA 4, where the
whole backbone is replaced by a pseudo peptide structure,21–23
is the most eﬀective and widely used.7–10 Nevertheless PNA suf-
fers from poor aqueous solubility and a tendency to aggregate.
In addition PNA is achiral and can bind in both a parallel and
antiparallel fashion with nucleic acid, which can jeopardise
sequence speciﬁcity.
The introduction of positive charges into the backbone of
oligonucleotide mimics is an alternative approach for increasing
the aﬃnity for complementary DNA and RNA. One of the
earliest examples reported was the deoxynucleic guanidine
(DNG) 5 oligomers, where the phosphodiester linkages in
DNA are replaced by cationic guanidinium groups.24 This
Fig. 1 Structure of POM and other related oligonucleotide mimics.
B = nucleobase (A, T, C or G).
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modiﬁcation was shown to vastly increase aﬃnity for comple-
mentary ssDNA and RNA. However, it remains to be seen if
such strong electrostatic attraction between oppositely charged
backbones results in non-speciﬁc binding, via salt bridges,
which may not necessitate base pairing and therefore may
not be evident from standard UV thermal denaturation
experiments.
As part of current research in our laboratory into the devel-
opment of backbone modiﬁed oligonucleotides, we recently
introduced the novel cationic pyrrolidine-amide oligonucleotide
mimic (POM).25 In this paper we describe the design rationale,
solution phase synthesis and conformational analysis of thym-
idyl T2-POM. Finally, the nucleic acid hybridisation properties
of a phthalimide capped T5-POM are discussed in detail.
Results and discussion
Design and molecular modelling
Pyrrolidine-amide Oligonucleotide Mimics (POM) 1 (Fig. 1)
are derived by replacing the furanose ring and phosphodiester
backbone in DNA with a (2R,4R)-conﬁgured pyrrolidine ring
and amide linkage, respectively. The pyrrolidine ring was
chosen because it will be substantially protonated at physio-
logical pH. Due to nearest neighbour interactions 26,27 it is anti-
cipated that only every other pyrrolidine would be protonated
at physiological pH. Nevertheless oligomers will possess high
water solubility and exhibit electrostatic attraction for comple-
mentary nucleic acids, possibly increasing aﬃnity. In this
respect it is similar to DNG 5.24 It was also envisaged that the
binding aﬃnity to DNA/RNA might be attenuated by changing
the ionic strength or pH, which may be an attractive property if
these molecules are to be used as probes, for example in DNA-
microarray type devices. In addition there is some evidence to
suggest that positively charged peptides and peptidomimetics
(like POM) could bind through electrostatic attraction to phos-
phate groups of the cell wall, which can aid transport through
the cell membranes.28 The amide linkage was selected to con-
nect the pyrrolidine units, since this group has been shown to be
a viable replacement for phosphodiester in the amide-linked
DNA mimics.19 Furthermore the amide linkage should facili-
tate the synthesis of POM using peptide chemistry and also
allow easy conjugation with peptides, in a similar fashion to
PNA.
The (2R,4R) stereochemistry of the pyrrolidine ring was
carefully selected because this should ensure that the
N-acetamido group will adopt the sterically less demanding
trans relative conﬁguration making the system a stereochemical
match with native nucleic acids. Of course the pyrrolidine
N-atom can invert conﬁguration via the free amine at a rate that
will depend on pH. However, X-ray crystallographic data 29 for
a protonated pyrrolidine ring 6, which is stereochemically iden-
tical and both electronically and sterically similar to the
pyrrolidine ring in POM, clearly show that the N-alkyl substi-
tuent adopts the trans relative stereochemistry, at least in the
crystalline state (Fig. 2). In addition the overall conformation
of 6, which is described by a pseudorotation phase angle (P) 30,31
of 43.7 and a maximum torsional angle (νmax) of 40.7, is simi-
lar to uridine 7 in the crystalline state (P = 14 and νmax = 42).32
In fact pyrrolidine 6 is only a few degrees of pseudorotation
out from the preferred C3-endo conformation of ribose in
RNA which typically falls within the range P = 0  36.31 As
such it was envisaged that the pyrrolidine unit of POM would
bear a closer conformational resemblance to native RNA and
more conservative mimics such as amide linked DNA 3 and
LNA 2 which similarly adopt a C3-endo sugar-conformation.
As a result of these critical stereochemical and conform-
ational features POM is predicted to bind in an antiparallel
fashion and diﬀers conceptually from other oligonucleotide
systems incorporating pyrrolidine units.33–40 These systems were
designed as conformationally restricted analogues of PNA,
unlike POM which we envisage shares little conformational or
electrostatic similarity with PNA.
In order to determine the relative energies of the diﬀerent
conﬁgurations and conformations of the pyrrolidine ring in
POM, semi-empirical quantum mechanical calculations 41 were
performed on the model thymidyl-pyrrolidine cis- and trans-
dimethyl diastereoisomers 8 and 9 (Fig. 3). Each conformer,
generated for every 10 degrees of pseudorotation, was ﬁrst
energy minimised allowing free rotation of the thymine base
about the C4-N1 bond in order to optimise the pseudo-glyco-
sidic torsion angle (χ). The standard enthalpies of formation
for each conformer were then calculated [see Fig. 3 and ESI
Table 1]. These reveal that, as predicted, the conformers gener-
ated for the trans-diastereoisomer 9 are on the whole lower
in energy than the cis. Moreover the lowest energy trans-
conformer A has a phase angle of 48 which is similar to the
crystal structure of pyrrolidine 6 and also just outside that
region of conformational space occupied by C3-endo ribose
typical for RNA.31 The trans-conformer B (P = 198) is 0.57
kcal mol1 higher in energy and analogous to a C2-endo deoxy-
ribose typically highly populated in DNA structures.
Whilst these ﬁndings are encouraging and suggest the most
highly populated conﬁguration and conformation will match
closely the RNA ribose structure, it should be noted these
Fig. 2 X-ray crystal structures of pyrrolidine derivative 6 29 and
uridine 7.32
Fig. 3 Variation in the standard enthalpies of formation (∆H ) with
pseudorotation phase angles (P) for model cis- and trans-dimethyl
pyrrolidines 8 and 9.
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studies do not account for intramolecular forces that may arise
in longer oligomers. For example, one could envisage a possible
H-bond extending from the protonated pyrrolidine N-atom to
an adjacent O-atom of the amide linkage in oligomeric POM 1.
Nevertheless intrastrand electrostatic repulsion should favour
the formation of an extended linear structure, with trans-
relative stereochemistry, and disfavour the formation of tightly
folded secondary structures, which might jeopardise base
pairing with complementary DNA and RNA.
Synthesis of a thymidyl-POM dimer
In order to investigate the conformational properties of POM,
using 1H NMR spectroscopy, the synthesis of a thymidyl-dimer,
T2-POM, was embarked upon ﬁrst. Accordingly the ester 10
(Scheme 1) was prepared from trans-4-hydroxy--proline 42 and
further transformed to the thymidyl-pyrrolidine 11 in an analo-
gous fashion to the corresponding methyl ester, which was pre-
pared earlier.33 Reduction of the ester 11 proceeded in 69%
yield with concomitant cleavage of the benzoyl-protecting
group to give the alcohol 12. Whilst the cleavage of the benzoyl
group was unexpected, it was nevertheless advantageous since
thymine-N3 protection was employed to ensure regioselectivity
in the previous Mitsunobu reaction,33 and was not envisaged to
be necessary for subsequent transformations. Initially we
sought to change the alcohol 12 to the corresponding amine 14
via the tosylate 15 and the azide 16. The tosylate 15 was thus
prepared in essentially quantitative yield, but upon heating to
80 C with LiN3 in DMF for 16 h surprisingly none of the
expected azide 16 was obtained. Instead the 6-enamine-bridged
tricyclic compound 18 was isolated as the major product. Pre-
sumably under the thermal conditions of substitution reaction
the azide 16 undergoes an intramolecular 1,3-dipolar cyclo-
addition with the C5–C6 double bond of the thymine ring.43,44
The resulting fused triazoline 17 presumably spontaneously
rearranges to give 18. In order to circumvent this, the alcohol 12
was converted into the corresponding phthalimide derivative
13 under standard Mitsunobu conditions. Removal of the
phthaloyl group from 13 proceeded in 92% yield on treatment
with 40% aqueous methylamine, at 40 C for 1 h, to furnish
amine 14.
Two diﬀerent approaches were envisaged for chain extension
of POM. In the ﬁrst approach N-alkylation of the pyrrolidine
19 with bromoacetamide 20 was investigated (Scheme 2).
Scheme 1
Accordingly a solution of the primary amine 14 in dry di-
chloromethane was added slowly to a 65% (w/v) solution of
bromoacetic anhydride in acetonitrile at 15 C, which resulted
in a near quantitative yield of the bromoacetamide 20. Removal
of the Boc protecting group from 13 under standard conditions
gave the secondary amine 19 as the TFA salt in essentially
quantitative yield. Coupling bromoacetamide 20 with this
amine salt 19 in the presence of Et3N and DMF, however, gave
the dinucleotide analogue 21 in a disappointingly low 58%
yield. A major side product from this reaction was the primary
alcohol 23. However, when this coupling was attempted using
DIPEA instead of Et3N, the yield of dimer 21 rose dramatically
to 98% with no observed side products. In both cases the reac-
tions were carried out under totally anhydrous conditions. It
seems most plausible that the less sterically hindered base tri-
ethylamine can deprotonate the acidic proton on thymine (N3H
pKa = 9.7) 31 to liberate a nucleophilic neighbouring group,
which could participate in an intramolecular SN2 displacement
of the bromide to give the lactam 22. This intermediate 22
could not be isolated probably because it undergoes facile
hydrolysis, either on TLC or during the aqueous workup, to
give the side-product 23.
Whilst the N-alkylation approach (19  20  21) using
DIPEA in DMF was excellent in terms of yield, the reaction
proceeded slowly at room temperature (18 h) and would there-
fore not be ideal for future application in the solid-phase syn-
thesis of POM. Dimer formation using an acylation approach
was therefore also investigated (Scheme 3). Thus amine 19
was treated with tert-butyl bromoacetate to give the ester 24,
which upon treatment with 20% TFA in dichloromethane gave
acid 25 as a TFA salt. This acid 25 was then transformed into
the pentaﬂuorophenyl ester 26 in 85% yield using pentaﬂuoro-
phenyl triﬂuoroacetate. Acylation of primary amine 14 with the
Pfp-ester 26 proceeded smoothly at room temperature in di-
chloromethane and after 3 h gave the protected dinucleotide
analogue 21 in quantitative yield.
In order to obtain the fully deprotected T2-POM 30 for
NMR-conformational studies, dinucleotide mimic 21 was
treated with methylamine, as before, in order to remove the
phthaloyl protecting group. However, three products were
isolated: the desired amine-dimer 27 as well as bicyclic lactam
28 and the amine-monomer 14. Clearly the basic conditions
required for removal of the phthaloyl group facilitate cyclis-
ation via the attack of the N-terminal amine on the central
amide linkage. This problem was overcome, to an extent, by
lowering the reaction temperature to room temperature and
stopping the reaction after only 40 min. This led to a mixture of
the desired product 27 and an intermediate, presumably the
ring-opened phthaloyl derivative 29. The latter was separated
Scheme 2
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Table 1 1H NMR conformational analysis of T2-POM3HCl 30
Vicinal H–H Observed 3JHH/Hz for 30
a
Calculated 3JHH/Hz
b
(dihedral angle HH/deg)
c
for conformer
Karplus parameters [r] d
A
P = 48
C
P = 38
B and D
P = 198 aj bj cj
2–3 9.9 a 10.2 b 10.0 1.3 9.6 0.99 1.2
  (157) c (155) (92)    
2–3 7.4 5.8 5.9 8.4 9.6 0.99 1.2
  (42) (41) (23)    
3–4 6.2 8.0 6.7 2.9 9.7 0.99 1.0
  (143) (136) (113)    
3–4 9.6 8.2 8.7 9.8 9.7 0.99 1.1
  (25) (20) (2)    
4–5 3.7 3.4 2.5 7.3 9.2 0.99 1.1
  (117) (110) (140)    
4–5 8.8 9.0 8.9 8.1 8.6 0.99 1.4
  (1) (7) (20)    
a The observed 3JHH coupling constants for the tri-substituted “upper” pyrrolidine ring of T2-POM3HCl 30. 
b The calculated 3JHH coupling
constants and c dihedral angles for the vicinal protons of the lowest energy conformers A–D of the model cis- and trans-dimethyl pyrrolidines 8 and 9
(Fig. 3). d The Karplus parameters aj, bj and cj derived previously for -4-hydroxyproline
45 were used in the generalised Karplus equation to calculate
3JHH (see Experimental section). 
and then treated with more methylamine to give amine 27 in a
combined yield of 75%. Treatment of the amine 27 with HCl
gave the totally deprotected hydrochloride salt T2-POM 30 that
was used in the following conformational studies.
NMR conformational analysis of T2-POM
In order to analyse the conformation of POM in aqueous solu-
tion, the tri-cationic T2-POM 30 was subjected to extensive 2D
1H NMR analysis. The 1H NMR spectrum of 30, in D2O, was
fully assigned with the aid of COSY-45, TOCSY, ROESY
and J-resolved experiments. Vicinal coupling constants were
obtained for every proton on the trisubstituted “upper”
pyrrolidine ring and these are shown in Table 1. Theoretical
coupling constants were also calculated, using a generalised
Karplus equation,45 and the dihedral angles obtained for the
four lowest energy conformers A, B, C and D, that were derived
previously from calculations performed on the model cis- and
trans-diastereoisomers 8 and 9 (Fig. 3). The experimentally
observed 3J values from T2-POM 30 were then compared with
the calculated 3JHH values of the model conformers (Table 1).
Scheme 3
Noticeably the H2–H3 coupling constant (3J23) of 9.9 Hz
observed for the upper ring of dimer 30 (Fig. 4) corresponds
well to the calculated values for both conformers A and C where
the H2–H3 dihedral angles (23) are 157 and 155 respect-
ively. In contrast both conformers B and D have identical
pucker (P = 198) and thus equivalent dihedral angles (23 =
92), which correspond to a typically small calculated 3J23 of
1.3 Hz. Similarly, the observed 3J34 and 
3J45 coupling con-
stants of 6.2 and 3.7 Hz correspond more closely with the calcu-
lated values for either structure A or C. Thus, the observed
3J values are in best overall agreement with the structures A
(P = 48) or C (P = 38), both of which are analogous to the
northern or C3-endo ribose ring conformations.
The analysis of 3J values provides no information regarding
the preferred conﬁguration of the pyrrolidine N-atom. In this
respect through space H–H correlations, as determined by
ROESY spectra, proved most useful. Notably H7/7–H2 and
H7/7–H5 ROE cross-peaks are observed for 30 (Fig. 4)
whereas no cross-peaks exist between H7/7 and H5 or H3.
This is most consistent with the trans N-conﬁguration of con-
formers A and B where the distances between H7/7 and H2 or
H5 are in the order of 2.5 Å. In addition, H7/7–H6/6 cross-
peaks are evident. This is most consistent with conformer A,
Fig. 4 Numbering system for the tri-substituted “upper” pyrrolidine
ring of T2-POM3HCl 30 and 3D structures of the lowest energy
conformers A and B of trans-dimethyl pyrrolidine 9 from Fig. 3.
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where the C7–C6 dihedral angle is 76 which places the corre-
sponding protons within 2.5 Å. However, in conformer B, the
corresponding dihedral angle is much larger, 155, which places
these protons more than 3.8 Å apart (Fig. 4). Interestingly,
H6–H3 and H6–H5 cross-peaks are also detected as well as a
H6–H4 cross-peak, which suggests that the thymine ring is in
equilibrium between the anti and syn conformations, relative to
the pyrrolidine ring. A similar conformational equilibrium is
often observed with natural nucleosides.31 In summary both
observed 3JHH coupling constants and ROEs for the tri-
substituted “upper” pyrrolidine ring in 30 are consistent with
the conformer A (Fig. 4). This conﬁguration and conformation
was also the lowest energy structure determined by modelling.
Whilst it is possible that the tri-substituted pyrrolidine ring in
30 is in equilibrium between several conformations, in solution,
the fact that the NMR and modelling studies are consistent
suggests that the most highly populated, lowest energy structure
is that which most closely matches a typical nucleotide in
RNA.
Synthesis of T5-POM
For our preliminary investigations into the nucleic acid hybrid-
isation properties of POM we decided to synthesise and evalu-
ate T5-POM. The synthesis toward T5-POM proceeded using
iterative alkylation of the pyrrolidine ring with the bromo-
acetamide 20 already in hand. Accordingly, Boc protected T2-
POM 21 was treated with triﬂuoroacetic acid to give the
secondary amine 31, as the TFA salt. Coupling of 31 with bro-
moacetamide 20 proceeds in DMF with excess DIPEA to give
Boc protected T3-POM 32, in near quantitative yield (Scheme
4). Repeating this Boc deprotection/coupling cycle leads to the
Boc protected T4- and T5-POM 33 and 34 respectively, in
similarly satisfactory yields after puriﬁcation by silica gel
chromatography. Complete assignment of the 1H and 13C NMR
spectra of these protected oligomers 32–34 was signiﬁcantly
complicated due to spectral overlap. Nevertheless the signals of
the thymine CH3 and C4 carbon atoms are clearly resolved in
the 13C NMR spectra recorded in CD3OD (see ESI Fig. 2),
whilst the thymine NH signals can be distinguished from the 1H
NMR in DMSO-d6 (see ESI Fig. 3). Attempts to remove the
phthaloyl group of Phth-T5-Boc POM 34, again using aqueous
methylamine, proved unsuccessful and were ultimately aban-
doned. It appears that base catalysed decomposition, involving
attack of the N-terminal amine on the central amide linkage to
give bicyclic lactam 28, is considerably more signiﬁcant in the
Scheme 4
case of the pentamer 34 than the dimer 21 (Scheme 3). Thus the
ﬁnal step in the synthesis was achieved by treating Phth-T5-Boc
POM 34 with aqueous hydrochloric acid. Evaporation and
lyophilisation gave Phth-T5-POM 35, as its HCl salt, which was
greater than 95% pure as determined by analytical reverse
phase HPLC (see ESI Fig. 4). All subsequent nucleic acid bind-
ing studies were carried out with this oligomer 35, retaining the
phthaloyl group. Subsequent as yet unpublished results have
indicated that the N-terminal phthaloyl moiety has little eﬀect
on DNA/RNA binding properties compared with N-acetyl
capped oligomers.
UV spectroscopic analysis of T5-POM–nucleic acid binding
properties
Phth-T5-POM binding poly(rA). UV thermal denaturation
experiments were performed in order to evaluate the aﬃnity of
Phth-T5-POM 35 upon hybridisation with RNA. Initially the
variation of absorption (A260) of an equimolar mixture of Phth-
T5-POM 35 and poly(rA) (42 µM each in bases) in 10 mM
K2HPO4 buﬀer adjusted to 0.12 M K
, pH 7.0, was recorded.
A complete cycle of the thermal induced denaturation and
renaturation involves fast heating (5 C min1), slow cooling
(0.2 C min1), followed by slow heating (0.2 C min1). The
slow heating curve resulted in a single 26% hyperchromic shift
with a melting temperature (Tm) of 48.5 C (ca. 10 C Tm/base)
(Fig. 5a). Under identical conditions corresponding native
d(T)5 did not show any hyperchromic shift with poly(rA) above
8 C, whilst the denaturation of d(T)20 and poly(rA) has a Tm of
42.0 C (ca. 2 C Tm/base). A T5-PNA containing a Lys residue
at either terminus exhibits similar aﬃnity for poly(rA), as Phth-
T5-POM 35, with a Tm of 56 C. While it is often hazardous to
extrapolate a Tm value obtained with homo-oligomers into an
accurate value of Tm per modiﬁcation found in a mixed
sequence, it is clear that Phth-T5-POM 35 binds with extremely
high aﬃnity to poly(rA). Thus it would seem that the pyrroli-
dine ring imposes a favourable conformation for hybridisation
with RNA. Based on results from modelling and NMR studies
(vide supra) this is likely to be, at least in part, a result of the
favourable northern C3-endo type conformation adopted by
the pyrrolidine ring.
Interestingly, substantial hysteresis was evident between the
cooling and heating curves in this experiment (see ESI Fig. 6)
indicating that the rate of heating/cooling employed (0.2 C
min1) is faster than the rate of association/dissociation of
Phth-T5-POM 35 and poly(rA) such that a true equilibrium is
not attained. This is in contrast to native duplex forming nucleic
acids which show essentially no hysteresis at this rate of tem-
perature change, implying Phth-T5-POM 35 hybridises more
slowly to poly(rA) than do native nucleic acids. Since it is
impossible to retrieve thermodynamic data unless the heating/
cooling curves are coincident, an even slower rate of heating/
cooling was employed. However, even at a heating/cooling rate
of 0.1 C min1, equilibrium conditions were still not realised.
Thus in order to obtain a true equilibrium Tm value, an equi-
molar sample of Phth-T5-POM 35 and poly(rA) was subjected
to a series of cooling/heating ramps performed at ﬁve diﬀerent
rates (5, 2, 1, 0.5 and 0.1 C min1). It was evident from these
curves that the slower rates of annealing result in higher Tm
values and greater hyperchromic shifts (see ESI Figs. 7 and 8).
By extrapolating to an inﬁnitely slow rate of heating/cooling,
the true equilibrium Tm was determined to be 49 C and is 0.5
C higher than that observed at 0.2 C min1. All further heat-
ing/cooling experiments were performed at 0.2 C min1 and
so the quoted Tm values are slightly lower than the true
equilibrium values and stand uncorrected.
Fidelity and stoichiometry of T5-POM binding RNA. In order
to assess the ﬁdelity of Phth-T5-POM 35 binding to RNA, UV
denaturation experiments were carried out with 35 and the
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Fig. 5 (a) UV thermal denaturation curves of Phth-T5-POM 35, Lys-T5-LysNH2-PNA (N- and C-terminal Lys, with C-terminal amide) and d(T)20
vs. poly(rA) (42 µM each in bases) in buﬀer A (10 mM K2HPO4) adjusted to 0.12 M K
, pH 7.0. (b) UV thermal denaturation curves for Phth-T5-
POM 35 and an equimolar amount (42 µM each strand in bases) of poly(rA), (rU), (rC) or (rG) in buﬀer A adjusted to 0.12 M K, pH 7.0. (c) A Job
plot of the % change in A260 vs. molar ratio Phth-T5-POM 35 and poly(rA).
non-complementary homopolymers poly(rG), (rC) and (U)
(Fig. 5b). In all three cases no signiﬁcant hyperchromicity is
observed, hence it can be concluded that Phth-T5-POM 35 does
not bind to the non-complementary homopolymers by a typical
base-pairing/stacking mechanism. These results do not, how-
ever, rule out non-speciﬁc binding, via electrostatic interactions
between the oppositely charged backbones.
A single hyperchromic shift was observed in the thermal
denaturation of Phth-T5-POM 35 and poly(rA) which is con-
sistent with the melting of a Watson and Crick base paired
duplex or the simultaneous dissociation of the three strands of
a TA.T triple helix. In order to determine the binding stoichio-
metry and discriminate between these two possibilities the
method of UV continuous variation was employed.46 Here UV
absorbance, over the range 220–300 nm, was measured as a
function of the molar ratio of bases, for mixtures of Phth-T5-
POM 35 and poly(rA). An incubation period of 24 h prior to
measurements was found to give the clearest results, presum-
ably due to the relatively slow rate of association between 35
and poly(rA). A Job plot 46 of the percentage change in A260
against mole ratio of T : A shows a well-deﬁned minimum at
1 : 1 consistent with duplex formation. In addition, the mini-
mum in the Job plot occurs at the intersection of two straight
lines, indicating a reversibly formed complex with few or no
vacant sites.47
Eﬀect of ionic strength and pH on Tm for Phth-T5-POM bind-
ing RNA. Bruice and co-workers showed that decrease in ionic
strength results in an increase in the binding aﬃnity of the
positively charged oligonucleotide DNG 5 (Fig. 1) to poly-
(dA) and poly(rA).48,49 This is due the “intimate” association
between the more “naked” oppositely charged backbones at
lower salt concentration. In order to determine whether electro-
static attraction could contribute to the stability of the duplex
formed between Phth-T5-POM 35 and poly(rA), melting
experiments were carried out at diﬀerent ionic strength over a
ten-fold concentration range. Surprisingly, there is actually a
slight increase in duplex stability with increasing ionic strength
between 0.12 and 1.2 M K (Tm = 48.5 and 55.0 C respect-
ively), which equates to an increase in Tm/base of ca. 1 C
(Fig. 6a). This implies that electrostatic attraction is not a major
contributing factor to the duplex stability. This may be a con-
sequence of either there being a relatively large distance
between the positive charge in POM and the negative charge of
the phosphodiester group in a duplex with RNA, or that Phth-
T5-POM 35 is only partially protonated at pH 7.0. In addition,
it may be that the observed increased aﬃnity of 35 for poly(rA)
at higher ionic strength is due to 35 adopting a slightly diﬀer-
ent conformation at higher salt concentration. It was also
noticeable from the UV melting curves, recorded at diﬀerent
salt concentrations, that the hyperchromicity decreases signiﬁ-
cantly, whilst hysteresis between the heating and cooling curves
increases, at higher ionic strengths (see ESI Fig. 9). This is
probably due to slower rates of association and dissociation at
higher ionic strength.
In order to assess the eﬀect of pH on the aﬃnity of Phth-T5-
POM 35 binding to poly(rA), melting experiments were carried
out at several diﬀerent pH values over the range 6–8 (10 mM
Fig. 6 (a) Transition melting temperatures per base (Tm/base) of Phth-
T5-POM 35, Lys-T5-LysNH2-PNA and d(T)20 with poly(rA) (42 µM
each in bases) in buﬀer A (total volume 1 mL) adjusted to the
appropriate ionic strength and pH. UV absorbance (A260) was recorded
with heating at 5 C min1 from 25 C to 93 C, cooling at 0.2 C min1
to 15 C and heating at 0.2 C min1 to 93 C. The Tm was determined
from the ﬁrst derivative of the ﬁnal slow heating curve. (b) Tm/base for
Phth-T5-POM 35, Lys-T5-LysNH2-PNA and d(T)20 with poly(dA). As
above except the mixture of 35 and poly(dA) (210 µM each in bases)
was incubated for 48–96 h at 25 C in buﬀer A (total volume 0.2 mL),
diluted to 1 mL adjusting to the appropriate ionic strength and pH,
cooled to 15 C at 1 C min1, heated at 0.2 C min1 to 93 C from
which the Tm was measured.
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phosphate buﬀer adjusted to 0.12 M K). This revealed that
there is a substantial increase in Tm from 45 to 57 C (∆Tm/base
= 2.1 C) on lowering the pH from 8.0 to 6.0 (Fig. 6a). Thus,
protonation of the nitrogen atom of the pyrrolidine ring is an
important factor in the formation of more stable duplexes. The
fact that duplex stability increases with salt concentration sug-
gests that conformational changes brought about by proton-
ation are more likely to be the cause of the observed increase in
duplex stability at lower pH, than electrostatic attraction. From
the melting curves (see ESI Fig. 10) it was again noticeable that
greater hyperchromic shifts and reduced hysteresis are observed
at lower pH, suggesting that binding occurs faster at lower pH.
The fact that there was signiﬁcant hysteresis between the heat-
ing and cooling curves even at pH 6.0 indicates binding is still
slow relative to native duplex hybridisation.
Phth-T5-POM binding DNA. In contrast to the distinct melt-
ing curves obtained with poly(rA), repeated UV heating/
cooling experiments with an equimolar mixture (42 µM each in
bases) of Phth-T5-POM 35 and poly(dA) revealed no hyper-
chromic shifts between 15 and 93 C. Surprisingly, a modest
cooperative hyperchromic shift could be detected after a ﬁve-
fold increased concentration of both 35 and poly(dA) (210 µM
each in bases, total volume 200 µL) was incubated at 25 C for
48 h, before the volume was readjusted to 1.0 mL (42 µM each
in bases) (Fig. 7a). However, the Tm of 57.0 C (11.4 C/base)
was only just detectable from the sloping baselines, indicating
only a fraction of the single strands had fully annealed. Thus
Phth-T5-POM 35 can hybridise with poly(rA) in the order of
minutes (at 42 µM each in bases), but remarkably only partially
hybridises with poly(dA) at a ﬁve-fold increased concentration
after an extended period of 2 days incubation. It is also of note
that although Phth-T5-POM 35 binds extremely slowly to
poly(dA), it does so with a higher aﬃnity than for poly(rA)
(increase in Tm of 8 C at 0.12 M K
, pH 7.0). In addition, 35
binds to poly(dA) with higher aﬃnity compared to Lys-T5-Lys-
PNA, which gave rise to a Tm of 48 C (9.6 C/base). All sub-
sequent Tm values for equimolar mixtures of 35 and poly(dA)
were obtained by incubating the two complementary strands at
a ﬁve-fold increased concentration (210 µM each in bases) for at
least 48 h prior to diluting the sample ﬁve-fold. While obtaining
Tm values with poly(dA) proved more diﬃcult than with
poly(rA), the trends appear the same for both series (Fig. 6b).
Phth-T5-POM 35 binds to poly(dA) with higher aﬃnity at
higher ionic strength and lower pH. In some cases two hyper-
chromic shifts could be detected, suggesting triplex formation.
However, due to the extremely slow binding kinetics, the stoi-
chiometry of binding could not be satisfactorily determined,
using the method of UV continuous variation. Indeed,
although the Job plot for 35 and poly(dA), obtained at an ionic
strength of 0.12 M and pH 7.0, gave a minimum at approx-
imately 30% T indicative of a TA.T triplex, this was poorly
deﬁned.
Following our initial communication of POM,25 it was
reported that incorporation of either one or two thymidyl-
pyrrolidine units, with the same stereochemistry as POM
(2R,4R), into ssDNA results in substantially destabilised
duplexes and triplexes, relative to wild-type, upon hybridisation
with complementary ssDNA and dsDNA, respectively.39 Our
results using a fully modiﬁed Phth-T5-POM 35 thus highlight
that it is clearly very hazardous, and unadvisable, to extrapolate
Tm values based on such a simple chimeric approach as a means
for understanding the nucleic acid binding properties of fully
modiﬁed novel nucleic acid mimics.
UV kinetic analysis of Phth-T5-POM binding DNA and RNA
Phth-T5-POM binds faster to RNA than DNA. Since UV
thermal denaturation experiments suggested there to be a sub-
stantial kinetic selectivity for Phth-T5-POM 35 binding to
poly(rA) over poly(dA), we decided to monitor the binding
events as a function of time. Initially absorbance changes at 260
nm were monitored at 25 C immediately upon mixing an
equimolar amount of 35 into a buﬀered solution containing
either poly(rA) or poly(dA) (42 µM each in bases, 0.12 M K,
pH 7.0). Under these conditions an hypochromic shift of 29%
was observed after 200 min upon mixing 35 with poly(rA)
(Fig. 7b). However when 35 was similarly mixed with poly(dA)
no drop in A260 was observed even after 16 h. It was only after
increasing the concentration of each strand ﬁve-fold to 210 µM
(in bases), that hybridisation between Phth-T5-POM and
poly(dA) can be observed. At this elevated concentration a
moderate absorbance drop of only ca. 6% was observed after
200 min, remarkably A260 was still dropping even after 12 h.
These experiments clearly conﬁrm that Phth-T5-POM 35 binds
much faster to RNA than DNA. Overall, however, it is also
evident that binding of Phth-T5-POM to poly(rA) is slow when
compared with Lys-T5-Lys-PNA. In an identical UV kinetic
experiment PNA hybridisation with poly(rA) (42 µM each in
bases) is essentially complete after 10 minutes, whilst Phth-T5-
Fig. 7 (a) UV thermal denaturation curves of Phth-T5-POM 35 vs.
poly(dA) following incubation for 48–96 h at 25 C in buﬀer A (210 µM
each in bases, 0.2 mL), ﬁve-fold dilution and adjustment of ionic
strength and pH. (b) Normalised UV absorbance (A260) of Phth-T5-
POM 35 with poly(rA) and (dA) vs. time at 25 C. 35 and poly(dA)
(42 µM each in bases), 0.12 M K, pH 7 (); 35 and poly(dA) (210 µM),
0.12 M K, pH 7 (); 35 and poly(rA) (42 µM), 0.22 M K, pH 7 (H17009);
35 and poly(rA) (42 µM), 0.12 M K, pH 7 (); 35 and poly(rA)
(42 µM), 0.12 M K, pH 6 ().
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POM fails to reach equilibrium even after 100 minutes (see ESI
Fig. 11).
To the best of our knowledge, there have been no reports of a
kinetically selective sequence speciﬁc association of a ligand for
RNA over ssDNA (or vice-versa). However other systems have
been reported to display weak but thermodynamically selective
binding for single stranded RNA over DNA. For example,
2,5-linked RNA,50 2,5-linked DNA 51 and 2,5-linked thio-
formacetal-modiﬁed 52 oligonucleotides all show substantial
thermodynamic selectivity for hetero-duplex formation with
RNA over ssDNA, albeit they bind with lower aﬃnity to com-
plementary RNA than do the corresponding isosequential
DNA oligonucleotides. At present we have no satisfactory
model to explain this kinetic selectivity of Phth-T5-POM for
poly(rA) over poly(dA) and further studies will be required to
delineate the mechanism of binding. Perhaps binding of
Phth-T5-POM to poly(dA) induces a major conformational
change to poly(dA) (or vice-versa), which retards further
binding. It is noteworthy that a chiral PNA thymidyl decamer
with a (2R,4R)-N-aminoethyl--proline backbone reported by
Vilaivan et al.,37 which diﬀers only in the position of the amide
group in the backbone, was also found to bind selectively to
poly(rA) and not poly(dA). However, no investigation into
binding kinetics was reported and it is thus tempting to postu-
late that longer incubation times would likewise reveal some
binding to poly(dA). Ganesh and co-workers found no such
selectivity with the stereoisomers (2S,4S ) and (2R,4S ) of this
N-aminoethyl proline based oligomer.38 However, these oligo-
mers 38 were chimeras with just one pyrrolidine unit incorpor-
ated in a standard PNA strand. Thus any conclusions that were
drawn from this work 38 are, at best, fragile.
Ionic strength and pH also aﬀect the rates of hybridisation.
Similar UV kinetic experiments were also carried out to deter-
mine the eﬀects of changing ionic strength and pH on the kinet-
ics of Phth-T5-POM 35 binding poly(rA) (see Fig. 7b and ESI
Figs. 12 and 13). This reveals that binding is much faster at
lower ionic strengths. This conﬁrms that greater hyperchromic
shifts observed in the UV thermal denaturation of Phth-T5-
POM 35/poly(rA) duplexes (vide supra) at lower ionic strengths
must arise from a higher percentage of duplex formed on
annealing due to faster rates of association. Furthermore,
these results suggest that electrostatic interactions are import-
ant in determining the kinetics of duplex formation. The results
for Phth-T5-POM 35 binding poly(rA) at diﬀerent pHs also
conﬁrm that binding is faster at pH 6 than at pH 7, which
in turn, is considerably faster than at pH 8. It is also notice-
able that the rates of binding are much less sensitive to pH
than to ionic strength. Unfortunately, the hybridisation of 35
with poly(rA) did not obey either ﬁrst order or pseudo ﬁrst-
order kinetics. Indeed no quantitative kinetic analysis was per-
formed using this data since as far as we are aware, no model
exists to account for the binding of a short ligand containing
several identical binding domains to a target bearing many
potential binding sites of which the degree of occupancy is
unknown.53
SPR analysis
Since UV spectroscopy can only detect changes in base stacking
interactions, it cannot be used to unequivocally ascertain the
speciﬁcity of binding of modiﬁed oligonucleotides to nucleic
acids. This was a particular concern since any non-speciﬁc
electrostatic backbone interactions between Phth-T5-POM 35
and complementary or non-complementary nucleic acids need
not involve a change in the extent of base-stacking. Surface
Plasmon Resonance (SPR) is a technique which is gaining
popularity for studying biomolecular interactions.54–56 Whilst it
has rarely been used for the study of modiﬁed oligonucleotide–
nucleic acid interactions, it can give rapid insight into kinetics
and thermodynamics and thus binding speciﬁcity.56 It was also
chosen as a complementary technique to UV spectroscopy in
order to observe more readily the slow interaction between
Phth-T5-POM 35 and poly(dA) since SPR permits the use of
higher analyte concentrations than is possible with UV spectro-
scopy. Accordingly 5-biotinylated targets, d(A)20 and r(A)20,
were immobilised onto a streptavidin loaded carboxymethyl-
dextran matrix of a standard SPR sensor chip (Biacore,
Stevenage). To ensure an equivalent number of binding sites,
d(A)20 and r(A)20 were injected across ﬂow cells 2 and 3 of the
four compartment sensor chip to give values of 1400 and 1450
response units (RU), respectively. In order to ensure against
non-speciﬁc electrostatic interactions that may have arisen from
the interaction between positively charged Phth-T5-POM 35
and the negatively charged carboxylate surface of the matrix,
one surface (ﬂow cell 1) was left underivatised. In addition, as a
control of Phth-T5-POM 35 binding speciﬁcity, the surface of
ﬂow cell 4 was derivatised with an ssDNA of mixed sequence,
5-biotin-d(AGC TTC AGA GAT CGA TCG GAG AGA
GTA CTG) (NFκB), to a value of 1000 RU. Having immobil-
ised the native oligonucleotides, Phth-T5-POM 35 was injected
at diﬀerent concentrations across all four ﬂow cells of the sen-
sor surface using a 10 mM K2HPO4 buﬀer adjusted to 0.12 M
K and pH 7.0. Typically, Phth-T5-POM 35 was injected across
the surfaces for 300 s followed by buﬀer alone. After this dis-
sociation phase, the surface was regenerated and any excess 35
was removed, by injecting a pulse of 10 mM HCl across the
surfaces.
Fig. 8a shows the sensogram obtained at a concentration of
40 µM and shows clearly that while Phth-T5-POM 35 associates
with d(A)20, it does so considerably slower than to r(A)20. Phth-
T5-POM 35 also shows no signiﬁcant binding to the negatively
charged carboxymethyl dextran matrix, conﬁrming the feasibil-
ity of using this type of sensor surface. Crucially, no binding
was observed to the mixed sequence control (NFκB), above
background, demonstrating that Phth-T5-POM 35 retains the
high ﬁdelity of base pair recognition displayed by native nucleic
acids and does not exhibit any non-speciﬁc binding through
electrostatic interactions. Furthermore when the concentration
of Phth-T5-POM 35 injected was increased two-fold (80 µM,
Fig. 8b) there was still no binding to the mixed sequence con-
trol, above the background. These results are also signiﬁcant in
that they prove that the hypochromic shifts observed upon
hybridising Phth-T5-POM 35 with poly(dA) compared to
poly(rA) are not an artefact of poor base stacking within the
Phth-T5-POM/poly(dA) complex relative to that of the Phth-
T5-POM/poly(rA) complex, but are due to a diﬀerence in
relative rates of association.
As a comparison, d(T)5 was injected across the sensor
surfaces. As expected, no duplex formation was observed
with d(A)20 or r(A)20 at concentrations even as high as 160
µM. This clearly reﬂects the much higher binding aﬃnity
of Phth-T5-POM 35 compared with its DNA 5mer counter-
part.
The eﬀect of ionic strength on the rates of association and
dissociation of Phth-T5-POM with d(A)20 and r(A)20 was
investigated using a buﬀer with an increase in KCl concen-
tration. This reveals that the rates of association to both r(A)20
and d(A)20 are very much reduced at higher ionic strength (see
ESI Fig. 14), consistent with observations obtained by UV
spectroscopy. As postulated previously, this is most likely due to
diminished inter-strand electrostatic attraction since the oppos-
itely charged backbones will eﬀectively be shielded from one
another by the presence of more counter ions in the solution.
However, it is also possible that conformational diﬀerences
arise at higher ionic strength which could be responsible for this
diﬀerence. Again, faster binding is observed to r(A)20 than to
d(A)20 at higher ionic strength, albeit the diﬀerence is slightly
diminished compared with a buﬀer of low ionic strength.
Nonetheless, this shows that the factors responsible for the
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kinetic selectivity of Phth-T5-POM 35 for binding RNA over
ssDNA are largely independent of ionic strength.
Next the eﬀect of pH on the rates of association, dissociation
and speciﬁcity of binding of Phth-T5-POM 35 with immobil-
ised native oligonucleotides was investigated. This revealed that
the overall trends at pH 6.0 are very similar to those at pH 7.0,
with Phth-T5-POM 35 binding much faster to r(A)20 relative to
d(A)20 (see ESI Fig. 15). Thus the factors responsible for the
kinetic selectivity prevail even at lower pH. Faster binding to
both targets was also observed at pH 6.0 compared with that at
pH 7.0, and is in agreement with the UV spectroscopic meas-
urements. This is likely to be a consequence of enhanced elec-
trostatic attraction between the more protonated Phth-T5-POM
and target nucleic acids. Notably, lowering the pH to 6.0 does
not result in any non-speciﬁc binding to the mixed sequence
above the background response of the underivatised surface.
However, when the same experiments were performed at pH 5.0
(0.12 M K), substantial binding to the mixed sequence ssDNA
(NFκB) was observed whereas very little binding to the dextran
was detected (see ESI Fig. 16). A fast rate of dissociation from
Fig. 8 SPR response (RU) vs. time for Phth-T5-POM 35 injected
across r(A)20, d(A)20, d(AGC TTC AGA GAT CGA TCG GAG AGA
GTA GTG-3) derivatised surfaces and an underivatised control
surface. Response proﬁles were determined using a BIAcore 2000
instrument (Biacore AB, UK) under standard conditions following
injection of Phth-T5-POM 35 (a) 40 µM and (b) 80 µM strand
concentration (in buﬀer A, pH 7 adjusted to 0.12 M K) across each
surface at a ﬂow rate of 20 µL min1 for 300 s, followed by buﬀer to
allow dissociation. All oligonucleotides were biotinylated at the 5-end
(Cruachem, UK) and immobilised on a streptavidin derivatised
carboxymethyl dextran sensor chip (Biacore).
NFκB is also observed, implying that the binding is weak. Thus
at pH 5.0, weak, non-speciﬁc interactions occur between Phth-
T5-POM 35 and ssDNA, presumably arising from electrostatic
attraction, such that the speciﬁc Watson–Crick type base-
pairing is disrupted. This also represents the ﬁrst example of a
modiﬁed oligonucleotide capable of switching from sequence
speciﬁc to sequence non-speciﬁc binding of a nucleic acid under
the control of an external stimulus (pH). Finally it is note-
worthy that the rate of dissociation of Phth-T5-POM 35 from
the mixed sequence ssDNA (NFκB) at pH 5.0 is much faster
than from d(A)20, suggesting that, in the presence of a comple-
mentary sequence, Phth-T5-POM binds to d(A)20 preferentially
via Watson–Crick type base-pairing.
Summary
An eﬃcient synthetic route to the highly water-soluble cationic
dinucleotide analogue T2-POM 30, has been developed. 
1H
NMR spectroscopy has shown that the N-acetamido group of
the protonated pyrrolidine ring in POM adopts a preferred
trans-conﬁguration relative to the base and thus the backbone
is stereochemically equivalent to native nucleic acids. Semi-
empirical quantum mechanical calculations carried out on di-
methylpyrrolidine nucleoside analogues also support this
observation. In addition, it was found that the pyrrolidine ring
preferentially adopts a conformation similar to the northern-
type conformation adopted by ribose in RNA. Moreover, since
the thymine base was found to be suitably oriented for
intermolecular hydrogen bonding, thymidyl POM satisﬁes the
necessary conﬁgurational and conformational requirements
for hybridisation with DNA and RNA.
Oligonucleotide analogues comprised of a pyrrolidine-
amide backbone are emerging as a new class of nucleic acid
mimics with desirable properties.36,37,40 Our preliminary studies
have found that the pyrrolidine-amide oligonucleotide mimics
(POM), in particular, exhibit many desirable, as well as
unforeseen properties. Solution-phase synthesis of the highly
water soluble thymidyl pentamer Phth-T5-POM was achieved
using an eﬃcient iterative N-alkylation strategy. UV spectro-
scopy and surface plasmon resonance have shown that Phth-
T5-POM binds with very high aﬃnity and speciﬁcity to com-
plementary ssDNA and RNA. Surprisingly, upon increasing
the ionic strength, slightly elevated Tm’s were observed, suggest-
ing that electrostatic attraction between oppositely charged
backbones does not play a signiﬁcant role in binding aﬃnity.
Decreasing the pH resulted in elevated Tm’s which is possibly a
consequence of conformational changes brought about by pro-
tonation of the pyrrolidine ring. By contrast, Phth-T5-POM
was found to bind to complementary RNA faster at lower ionic
strength and pH, implying that electrostatic interactions are
important in determining the kinetics of hybridisation. SPR
analysis has also shown unequivocally that Phth-T5-POM
maintains the ﬁdelity of sequence speciﬁc binding (base-
pairing) observed with native nucleic acids, at both pH 7.0 and
6.0. However, at pH 5.0 the cationic oligonucleotide was
attracted to a non-complementary ssDNA, presumably via
electrostatic contacts between oppositely charged backbones.
Intriguingly, Phth-T5-POM was found to bind much faster to
RNA than to DNA. We are currently developing a solid-phase
synthesis of longer mixed sequence POM in order to explore in
greater depth this kinetically selective recognition, which may
provide new insight into the conformational diﬀerences
between the two native nucleic acid forms.
Experimental section
1H NMR spectra were recorded at 270, 300, 400 or 500 MHz.
13C NMR spectra were recorded at 67.9, 75.5, or 100.6 MHz.
Chemical shifts are reported in parts per million relative to
Me4Si or residual solvent signal. 
19F NMR spectra were
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recorded at 188.2 MHz unreferenced. FAB mass spectra were
obtained on a ZAB-SE VG Analytical Fisons Instrument. Elec-
tron Impact (EI) and Chemical Ionisation (CI) mass spectra
were recorded using a VG Analytical 70 70 EQ mass spectro-
meter using NH3 as carrier gas. Electrospray ionisation (ESI)
mass spectra were performed, in positive ion mode, using a Q-
Tof (Micromass, Manchester). Infra-red spectra were acquired
on a Perkin-Elmer 783 as KBr discs or CHCl3 solutions. Melt-
ing points were determined using a Cambridge Instrumental
microscope with a Reichert-Jung heating mantle and are un-
corrected. Optical rotations were measured at 20 C with an
Optical Activity AA-1000 polarimeter. Flash silica column
chromatography was carried out over Merck Kieselgel 60 (230–
400 mesh) and Merck Kieselgel 60 F254 0.25 mm plates were
used for analytical TLC. Reactions involving anhydrous condi-
tions were carried out in ﬂame-dried glassware under a posi-
tive pressure of argon. All solvents were distilled before use.
Reagents were puriﬁed and solvents dried using standard
procedures.
Molecular modelling
Co-ordinates of X-ray crystal structures of uridine 7 32 and a
pyrrolidine HCl salt 6 29 (Fig. 2) were obtained from the Cam-
bridge Crystallographic Database. The pseudorotation phase
angle (P) and degree of pucker or maximum torsional angle
(νmax) are calculated by substituting the published torsion
angles (ν0  ν4) into the equations: Tan P = {(ν4  ν1)  (ν3 
ν0)}/{2  ν2  (sin 36  sin 72)}and νmax = ν2/cos P.30,31 Models
of the cis- and trans-dimethylpyrrolidines 8 and 9 (Fig. 3) were
built from the co-ordinates of the reported crystal structure of
pyrrolidine 6. For both diastereoisomers 35 conformations, for
every 10 degrees of pseudorotation, were energy minimised,
allowing only free rotation of the thymine base about the C4–
N1 bond, in order to optimise the C3–C4–N1–O2 torsion
angle which is analogous to the glycosyl torsion angle in native
nucleic acids (χ).31 The enthalpies of formation for each con-
former were then calculated by semi-empirical quantum mech-
anical calculations using MOPAC 6.0 software 41 on a Silicon
Graphics workstation. The maximum torsional angle (νmax) was
optimised to 40. The standard enthalpies of formation, phase
angles (P), cyclic torsion angles ν0  ν4, and the torsion angle
C3–C4–N1–C2 (χ for conformers A–D) are shown in ESI
(Table 1). The structures of conformers A and B are shown in
Fig. 4.
NMR conformational analysis
NMR spectra of T2-POM3HCl 30 (ca. 4 mg) dissolved in
99.9% D2O (0.5 ml) were recorded at 500 MHz on a Bruker
DRX500 at 30 C and referenced to the residual HDO peak at
4.70 ppm. A 1H spectral width of 5000 Hz was used through-
out. 2D TOCSY, COSY 45, ROESY and J-resolved spectra
were collected using 8k data points in t2 and 256 t1 increments,
typically zero-ﬁlled to 8k × 512 data points, with a relaxation
delay of 2 seconds. Suppression of residual solvent signal
(HDO) was achieved using presaturation during the relaxation
delay. ROESY and TOCSY spectra had typical mixing times
of 300 and 60 ms respectively. The assignment of all proton
chemical shifts, vicinal coupling constants, and ROESY cross
peaks are given in ESI. The observed 3JHH coupling constants
for the tri-substituted (upper) pyrrolidine ring of T2-POM
3HCl 30 (Table 1) were compared with the calculated 3JHH
coupling constants for the corresponding vicinal protons for
the lowest energy conformers A–D of the model cis- and
trans-dimethylpyrrolidines 8 and 9 (Fig. 3). The calculated 3JHH
coupling constants are derived from the general Karplus equa-
tion J j = aj cos2   bj cos   cj.45 The Karplus parameters
used in the calculations, aj, bj and cj, are listed in Table 1 and are
the same as those derived for -4-hydroxyproline.45
N-(tert-Butoxycarbonyl)-trans-4-formyloxy-D-proline ethyl
ester. Ph3P (9.47 g, 36.0 mmol), followed by dry formic acid
(1.4 mL, 37.0 mmol), was added to a stirred solution of
N-(tert-butoxycarbonyl)-cis-4-hydroxy--proline ethyl ester
10 42 (7.6 g, 29.0 mmol) in dry THF (125 mL) under argon. The
mixture was then cooled to 20 C and diisopropyl azodicarb-
oxylate (DIAD) (7.3 mL, 37.0 mmol) was added dropwise over
30 min. The solution was held at 20 C for a further 15 min
and then allowed to warm to room temperature and stirred for
a further 18 h. The resulting yellow solution was evaporated
under reduced pressure, and Et2O (ca. 50 mL) was added to
precipitate triphenylphosphine oxide which was removed by ﬁl-
tration. The ﬁltrate was evaporated under reduced pressure and
the residue was puriﬁed by ﬂash chromatography, eluting with
5% acetone in CH2Cl2, to give the title compound (7.62 g, 90%)
as a pale yellow oil. Rf 0.28 (5% acetone in CH2Cl2); [α]D 46.5
(c = 2.0, EtOH); δH (300 MHz, CDCl3) 1.28–1.38 (3H, m,
CH2CH3), 1.44 and 1.47 (total 9H, 2 × s, C(CH3)3 rotamers),
2.20–2.29 (1H, m, Ha3), 2.39–2.49 (1H, m, Hb3), 3.58–3.74 (2H,
m, H5), 4.22 (2H, q, J 7.0, CH2CH3), 4.34–4.47 (1H, 2 × t, each
J 7.9, H2 rotamers), 5.43 (1H, br s, H4), 8.02 and 9.21 (total
1H, 2 × s, HCO rotamers); δC (100.6 MHz, CDCl3) 14.5
(CH2CH3), 28.6 and 28.7 (C(CH3)3 rotamers), 35.8 and 36.9
(C3 rotamers), 52.2 and 52.5 (C5 rotamers), 57.9 and 58.2 (C2
rotamers), 61.6 (CH2CH3), 71.1 and 72.0 (C4 rotamers), 81.0
(C (CH3)3), 153.9 and 154.4 (CO2
tBu rotamers), 160.4 and 160.5
(HCO2 rotamers), 172.6 and 172.8 (CO2Et rotamers); m/z
(FAB) 288 ([M  H], 53%), 260 (45), 232 (47), 188 (63);
HRMS m/z (CI) 288.1451 ([M  H], C13H22NO6 requires m/z,
288.1447).
N-(tert-Butoxycarbonyl)-trans-4-hydroxy-D-proline ethyl
ester. 25% aq. NH3 (1.8 mL) was added to a solution of N-(tert-
butoxycarbonyl)-trans-4-formyloxy--proline ethyl ester (3.50
g, 13.4 mmol) in CH3OH (30 mL) and the mixture was then
stirred at room temperature for 5 h. Evaporation of solvent
under reduced pressure and subsequent puriﬁcation by ﬂash
chromatography, using ethyl acetate as eluant, gave the title
compound (2.90 g, 91%) as a viscous transparent oil. Rf 0.35
(3 : 1 ethyl acetate–hexane); [α]D 67.4 (c = 2.0, EtOH) [lit.42
[α]D 70.4 (c = 2.0, EtOH)]; δH (300 MHz, CDCl3) 1.28 (3H, t,
J 7.2, CH2CH3), 1.41 and 1.46 (total 9H, 2 × s, C(CH3)3
rotamers), 2.00–2.17 (1H, m, Ha3), 2.18–2.65 (2H, m, Hb3 and
OH), 3.40–3.71 (2H, m, H5), 4.17 and 4.18 (total 2H, 2 × q,
J 7.2, CH2CH3 rotamers), 4.32–4.44 (1H, m, H2), 4.45–4.53
(1H, m, H4); δC (100.6 MHz, CDCl3) 14.6 (CH2CH3), 28.6
(C(CH3)3), 38.8 and 39.5 (C3 rotamers), 55.1 (C5), 58.1 and
58.4 (C2 rotamers), 61.4 (CH2CH3), 69.7 and 70.5 (C4 rota-
mers), 80.7 (C (CH3)3), 154.5 (CO2
tBu), 173.3 and 173.5 (CO2Et
rotamers); m/z (FAB) 260 ([M  H], 50%), 204 (96), 160
(100); HRMS m/z (CI) 260.1501 ([M  H], C12H22NO5
requires m/z, 260.1498).
cis-4-(N 3-Benzoylthymin-1-yl)-N-(tert-butoxycarbonyl)-D-
proline ethyl ester (11). Diethyl azodicarboxylate (DEAD)
(1.0 mL, 6.37 mmol) was added dropwise over 1 h to a solution
of N-(tert-butoxycarbonyl)-trans-4-hydroxy--proline ethyl
ester (1.50 g, 5.79 mmol), N 3-benzoylthymine 33 (1.33 g, 5.79
mmol) and Ph3P (1.72 g, 6.37 mmol) in THF (50 mL) at
15 C. The mixture was warmed to room temperature and
stirred for 18 h. Evaporation under reduced pressure and puriﬁ-
cation by column chromatography, eluting with 5% acetone in
CH2Cl2 and then 5% CH3OH in CH2Cl2, gave the ester 11 (1.69
g, 62%) as a white foam. Rf 0.70 (5 : 1 CH2Cl2–acetone); [α]D
9.9 (c = 2.0, CH2Cl2); νmax (KBr)/cm1 1731 and 1692 (CO);
λmax (CH3OH)/nm 270 (ε/dm
3 mol1 cm1 11000); δH (300 MHz,
CDCl3) 1.24 (3H, t, J 7.1, CH2CH3), 1.35 and 1.39 (total 9H,
2 × s, C(CH3)3), 1.92 (3H, d, J 0.8, thymine CH3), 1.97–2.14
(1H, m, Ha3), 2.65–2.83 (1H, m, Hb3), 3.38–3.71 (1H, m,
Ha5), 3.90 (1H, dd, J 11.9, 7.7, Hb5), 4.17 (2H, q, J 7.1,
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CH2CH3), 4.22–4.43 (1H, m, H2), 5.18 and 5.35 (total 1H,
2 × br s, H4 rotamers), 7.31 (1H, s, H6), 7.42 (2H, t, J 7.5, Bz
m-H), 7.58 (1H, t, J 7.5, Bz p-H), 7.84 (2H, d, J 7.1, Bz o-H);
δC (100.6 MHz, CDCl3) 12.5 and 13.0 (thymine CH3 rotamers),
14.6 (CH2CH3), 28.6 (C(CH3)3), 36.1 and 36.5 (C3 rotamers),
49.9 (C5), 52.8 (C4), 57.9 (C2), 61.6 and 62.0 (CH2CH3
rotamers), 81.6 (C (CH3)3), 112.1 (C5), 129.1 and 129.5 (Bz m-C
rotamers), 130.8 (Bz o-C), 132.0 (Bz ipso-C), 135.4 (C6), 136.4
(Bz p-C), 150.3 (C2), 153.8 and 154.1 (CO2
tBu rotamers), 162.2
and 162.8 (C4 rotamers), 169.2 (COPh), 172.8 (CO2Et); m/z
(FAB) 472 ([M  H], 20%), 416 (36), 372 (20); HRMS m/z
(CI) 472.2081 ([M  H], C24H30N3O7 requires m/z, 472.2083).
N-(tert-Butoxycarbonyl)-cis-4-(thymin-1-yl)-D-prolinol (12).
Lithium borohydride (49 mg, 2.24 mmol) was added portion-
wise over 1 h to a solution of ethyl ester 11 (0.53 g, 1.12 mmol)
in dry THF (10 mL) at 0 C. Stirring was continued at 0 C for a
further 30 min, then the mixture was allowed to warm to room
temperature and stirred overnight. The reaction was cooled to
0 C, quenched by the addition of methanol (20 mL), and evap-
orated under reduced pressure. Saturated aq. NaCl (20 mL) was
then added and the mixture was extracted with CHCl3–EtOH
(2 : 1 v/v, 6 × 20 mL), dried over anhydrous MgSO4, ﬁltered and
evaporated under reduced pressure. Puriﬁcation by column
chromatography, eluting with 5% CH3OH in CH2Cl2, gave the
alcohol 12 (0.250 g, 69%) as a white solid. Rf 0.12 (5% CH3OH
in CH2Cl2); mp 79–81 C (from hexane–ethyl acetate); [α]D
10.6 (c = 2.0, CH2Cl2); νmax (KBr)/cm1 3412 and 3188 (OH),
1689 (CO); λmax (CH3OH)/nm 270 (ε/dm
3 mol1 cm1 8800);
δH (300 MHz, CDCl3) 1.49 (9H, s, C(CH3)3), 1.96–2.00 (4H, m,
thymine CH3 and Ha3), 2.40–2.49 (1H, m, Hb3), 3.27 (1H, dd,
J 10.9, 9.8, Ha5), 3.69 (1H, dd, J 11.3, 5.6, CHaHbOH), 3.92
(1H, d, J 10.9, Ha5), 3.98–4.10 (2H, m, CHaHbOH and H2),
5.05–5.11 (1H, m, H4), 7.13 (1H, s, H6), 8.25 (1H, s, H3);
δC (67.9 MHz, CDCl3) 12.5 (thymine CH3), 28.3 (C(CH3)3),
32.2 (C3), 49.8 (C5), 51.8 (C4), 58.6 (C2), 65.5 (CH2OH),
81.2 (C (CH3)3), 111.7 (C5), 135.9 (C6), 151.1 (C2), 155.9
(CO2
tBu), 163.4 (C4); m/z (FAB) 348 ([M  Na], 25%), 326
([M  H], 43), 270 (64), 226 (100); HRMS m/z (FAB)
326.1717 ([M  H], C15H24N3O5 requires m/z, 326.1716).
N-tert-Butoxycarbonyl-cis-4-(thymin-1-yl)-D-prolinol
p-toluenesulfonate (15). Tosyl chloride (121 mg, 0.63 mmol) was
added to a solution of alcohol 12 (103 mg, 0.32 mmol) in dry
pyridine (1.0 mL) at 0 C and the mixture was stirred for 15
min, allowed to warm to room temperature and stirred for a
further 18 h. CH3OH (10 mL) and water (5 mL) were slowly
added and the mixture was then evaporated under reduced
pressure. Puriﬁcation by ﬂash chromatography (0 10%
CH3OH in CH2Cl2) gave the tosyl derivative 15 (150 mg, 99%)
as a white foam. [α]D 5.8 (c = 0.12, CH2Cl2); νmax (KBr)/cm1
1700 br (CO), 1400 (SO2 and C(CH3)3), 1385 (C(CH3)3), 1165
(SO2), 807 (Ar-H); δH (270 MHz, CDCl3) 1.32 (9H, s, C(CH3)3),
1.91 (3H, s, thymine-CH3), 1.93–2.14 (1H, m, Ha3), 2.38 (3H, s,
Ar-CH3), 2.45–2.58 (1H, m, Hb3), 3.05–3.20 (1H, m, Ha5),
3.86–3.94 (1H, m, Hb5), 4.00–4.15 (2H, m, CH2OSO2), 4.22–
4.55 (1H, m, H2), 5.00–5.23 (1H, m, H4), 7.19 (1H, br s, H6),
7.36 (2H, d, J 8.3, Ar), 7.78 (2H, d, J 8.3, Ar), 9.34 (1H, s, NH);
δC (67.9 MHz, CDCl3) 12.5 (thymine CH3), 21.6 (Ar CH3), 28.4
(C(CH3)3), 31.5 (C3), 49.4 (C5), 51.4 (C4), 54.5 (C2), 70.3
(CH2OSO2), 80.9 (C (CH3)3), 112.3 (C5), 127.8 and 130.1 (Ar
CH), 132.7 (Ar CCH3), 135.7 (C6), 145.3 (Ar CSO2), 150.9
(C2), 153.5 (Boc CO), 163.1 (C4); m/z (FAB) 612 ([M  Cs],
27%), 394 (100), 345 (43), 312 (47), 286 (90); HRMS m/z
(FAB) 612.0792 ([M  Cs], C22H29N3O7SCs requires m/z,
612.0781).
N-(tert-Butoxycarbonyl)-(2R,4R )-6,2-imino(methyl)-4-
(thymin-1-yl)pyrrolidine (18). Lithium azide (45 mg, 0.93 mmol)
was added to a solution of tosyl derivative 15 (111 mg, 0.23
mmol) in dry DMF (1 mL) and the mixture was stirred at 80 C
for 16 h. The solution was allowed to cool to room temperature
whereupon saturated brine (10 mL) was added. The mixture
was extracted with ethyl acetate (4 × 10 mL), dried over
anhydrous MgSO4, ﬁltered and evaporated under reduced
pressure. Puriﬁcation by column chromatography (10%
CH3OH in CH2Cl2) gave the enamine 18 (38 mg, 72% based on
unrecovered starting material) as a white crystalline solid. Rf
0.31 (10% CH3OH in CH2Cl2); δH (300 MHz, CDCl3) 1.47 and
1.49 (total 9H, 2 × s, C(CH3)3 rotamers), 1.76 (1H, d, J 13.6,
Ha3), 1.90 (3H, s, thymine CH3), 2.26–2.48 (1H, m, Hb3), 3.03
(1H, t, J 13.2, NHCHaHb), 3.46 (1H, t, J 12.4, Ha5), 3.62–3.87
(2H, m, Hb5 and NHCHaHb), 4.20–4.42 (1H, m, H2
rotamers), 5.96 (1H, t, J 7.4, H4), 9.37 (1H, br s, NH);
δC (100.6 MHz, CDCl3) 9.4 (thymine CH3), 28.8 (C(CH3)3),
37.7 and 38.3 (C3 rotamers), 50.0 and 50.9 (NHCH2 rotamers),
51.6 and 51.9 (C5 rotamers), 53.1 and 54.1 (C4 rotamers), 54.2
and 54.6 (C2 rotamers), 80.5 (C (CH3)3), 91.3 and 91.6 (C5
rotamers), 151.2 (C2), 153.6 and 153.9 (C6 rotamers), 154.3
and 154.5 (Boc CO rotamers), 163.2 (C4); m/z (FAB) 345
([M  Na], 17%), 323 ([M  H], 100), 267 (92); HRMS
m/z (FAB) 323.1702 ([M  H], C15H23N4O4 requires m/z,
323.1719).
N-(tert-Butoxycarbonyl)-(2R,4R )-2-[(phthalimido)methyl]-
4-(thymin-1-yl)pyrrolidine 13. PPh3 (833 mg, 3.18 mmol) and
phthalimide (470 mg, 3.18 mmol) were added to a solution of
alcohol 12 (794 mg, 2.44 mmol) in dry THF (20 mL). The
mixture was stirred at 15 C and DEAD (500 µL, 3.18 mmol)
was added dropwise over 20 min. After a further 30 min the
reaction was warmed to room temperature and stirred for 18 h.
Evaporation under reduced pressure and subsequent puriﬁ-
cation by column chromatography (ethyl acetate) gave the
phthalimide derivative 13 (690 mg, 63%) as a white solid. Rf
0.3 (ethyl acetate); mp 102–105 C (from hexane–ethyl acetate);
[α]D 54.0 (c = 1.56, CH2Cl2); νmax (CHCl3)/cm1 3686, 3396,
1774 (Phth CO), 1718 and 1692 (CO); δH (270 MHz, CDCl3)
1.33 (9H, br s, C(CH3)3), 1.96 (3H, d, J 0.6, thymine CH3),
1.92–2.05 (1H, m, Ha3), 2.43–2.51 (1H, m, Hb3), 3.41 (1H,
dd, J 11.9, 7.4, Ha5), 3.71–3.77 (1H, m, Hb5), 3.88–
4.09 (2H, m, Phth-CH2), 4.22–4.42 (1H, m, H2), 4.93–4.99
(1H, m, H4), 7.28 (1H, s, H6), 7.66–7.74 (2H, m, Ar), 7.79–
7.86 (2H, m, Ar), 9.26 (1H, s, NH); δC (67.9 MHz, CDCl3)
12.4 (thymine CH3), 28.2 and 28.3 (C(CH3)3 rotamers), 33.9
(C3), 41.6 (Phth-CH2), 48.5 and 48.6 (C5 rotamers), 53.4
(C4), 54.4 (C2), 80.8 (C (CH3)3), 111.6 (C5), 123.3 and 134.0
(ArCH), 132.1 (ArC ipso), 136.4 (C6), 150.9 (C2), 154.4
(Boc CO), 163.5 (C4), 168.4 (Phth CO); m/z (FAB) 477
([M  Na], 5%), 455 ([M  H], 8), 400 (7), 355(100); HRMS
m/z (FAB) 455.1924 ([M  H], C23H27N4O6 requires m/z,
455.1931).
N-(tert-Butoxycarbonyl)-(2R,4R )-2-[(amino)methyl]-4-
(thymin-1-yl)pyrrolidine (14). A solution of phthalimide deriv-
ative 13 (340 mg, 0.88 mmol) in a 25–30% aqueous solution of
methylamine (2 mL) was heated at 40 C for 1 h. Evaporation
under reduced pressure followed by column chromatography
(20% CH3OH in CH2Cl2) gave the amine 14 (253 mg, 89%) as a
white solid. Rf 0.28 (30% CH3OH in CH2Cl2); mp 116–118 C
(from CH3OH–CH2Cl2); [α]D 22.1 (c = 0.54, CH3OH); νmax
(CHCl3)/cm
1 3680, 3390, 3020, 1690 (CO), 1470; δH (270 MHz,
CD3OD) 1.47 (9H, s, C(CH3)3), 1.89 (3H, d, J 1.1, thymine
CH3), 2.09–2.23 (1H, m, Ha3), 2.33–2.46 (1H, m, Hb3), 2.94
(2H, d, J 4.9, CH2NH2), 3.26–3.37 (1H, m, Ha5), 3.81–4.00
(2H, m, Hb5 and CH2), 4.68–4.92 (1H, m, CH4), 7.57 (1H, d,
J 1.1, H6); δC (67.9 MHz, CD3OD) 12.3 (thymine CH3), 28.7
(C(CH3)3), 33.7 (C3), 45.3 (CH2NH2), 50.1 (C5), 54.4 (C4),
59.1 (C2), 81.7 (C (CH3)3), 111.8 (C5), 139.5 (C6), 153.0 (C2),
156.4 (Boc CO), 166.3 (C4); m/z (FAB) 455 ([M  Cs], 13%),
347 ([M  Na], 20), 325 ([M  H], 100), 225 (96), 175 (43);
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HRMS m/z (FAB) 325.1864 ([M  H], C15H25N4O4 requires
m/z, 325.1876).
(2R,4R )-2-[(Phthalimido)methyl]-4-(thymin-1-yl)pyrrol-
idine triﬂuoroacetic acid salt (19). CF3CO2H (2.0 mL) was
added to a solution of phthalimide derivative 13 (830 mg, 1.83
mmol) in dichloromethane (4.0 mL). After stirring at room
temperature for 4 h the solution was reduced in volume under a
stream of argon to give a thick oil. On addition of diethyl ether
(5.0 mL) and cooling to 0 C, a precipitate formed which was
ﬁltered and dried to give the desired amine salt 19 (740 mg,
86%) as a white solid. [α]D 46.3 (c = 0.19, 10% CH3OH in
CH2Cl2); λmax (EtOH)/nm 219 (ε/dm
3 mol1 cm1 45050); δH
(400 MHz, DMSO-d6) 1.79 (3H, s, thymine CH3), 1.99–2.03
(1H, m, Ha3), 2.54–2.64 (1H, m, Hb3), 3.37–3.59 (2H, m,
H5), 3.80–3.86 (1H, m, H2), 3.93–4.04 (2H, m, Phth-CH2),
5.14–5.22 (1H, br m, H4), 7.66 (1H, d, J 1.0, H6), 7.85–7.95
(4H, m, Ar), 8.90 and 9.80 (each 1H, br s, NH1), 11.42 (1H, s,
thymine NH); δC (100.6 MHz, DMSO-d6) 12.1 (thymine CH3),
32.9 (C3), 37.7 (C5), 48.0 (Phth-CH2), 53.6 (C4), 58.2 (C2),
109.7 (C5), 117.1 (q, J 299.2, CF3), 123.2, 131.7 and 134.5 (3 ×
Ar), 138.6 (C6), 151.2 (C2), 158.4 (q, J 31.3, CF3CO), 163.7
(C4), 167.9 (Phth CO); m/z (FAB) 355 (M, 100%), 307 (12),
176 (14); HRMS m/z (FAB) 355.1393 (M, C18H19N4O4
requires m/z, 355.1406).
N-(tert-Butoxycarbonyl)-(2R,4R )-2-[(bromoacetamido)-
methyl]-4-(thymin-1-yl)pyrrolidine (20). To a 65% (w/v) solu-
tion of bromoacetic anhydride (13 µL, 0.031 mmol) in
acetonitrile was added dichloromethane (500 µL). This was
cooled to 8 C and a solution of amine 14 (10 mg, 0.031
mmol) in dichloromethane (1 mL) was added. After 5 min, the
ﬂask was warmed to room temperature and evaporated under
reduced pressure. Column chromatography (5 10% CH3OH
in CH2Cl2) gave the bromoacetamide 17 (13.4 mg, 97%) as a
white solid. Rf 0.29 (5% CH3OH in CH2Cl2); mp 90–92 C (from
CH3OH–CH2Cl2); [α]D 38.1 (c = 0.16, CH3OH); λmax (EtOH)/
nm 270.7 (ε/dm3 mol1 cm1 20852); δH (400 MHz, CD3OD)
1.49 (9H, s, C(CH3)3), 1.88 (3H, d, J 1.1, thymine CH3), 2.04–
2.22 (1H, m, Ha3), 2.34–2.48 (1H, m, Hb3), 3.27–3.41 (1H, m,
Ha5), 3.53–3.64 (2H, m, CH2Br), 3.87 (2H, d, J 2.4, NHCH2),
3.88–4.12 (2H, m, Hb5 and H2), 4.72–4.96 (1H, m, H4), 7.45
(1H, d, J 1.1, H6); δC (67.9 MHz, CD3OD) 12.5 (thymine CH3),
28.7 (C(CH3)3), 29.1 (CH2Br), 33.4 (C3), 43.3 (CH2NH), 50.0
C(5), 54.7 (C4), 57.1 (C2), 81.8 and 81.9 (C (CH3)3 rotamers),
111.7 (C5), 139.4 and 139.5 (C6 rotamers), 152.8 (C2), 156.2
(Boc CO), 166.2 (C4), 170.1 (BrCH2CO); m/z (FAB
) 469 ([M
 Na], 5%)‡, 467 ([M  Na], 4) §, 447 ([M  H], 10)‡, 445 ([M
 H], 10) §, 347 (100), 345 (98), 314 (84); HRMS m/z (FAB)
445.1090 ([M  H], C17H26N4O5
79Br requires m/z, 445.1087).
Phth-T2-Boc-POM (21)
Triethylamine (24 µL, 0.172 mmol) was added to a solution of
amine 19 (20 mg, 0.043 mmol) and bromoacetamide 20 (19 mg,
0.043 mmol) in dry DMF (0.5 mL). This mixture was stirred at
room temperature for 16 h, then evaporated under reduced
pressure. A 10% (w/v) K2CO3 solution in saturated brine (5 mL)
was added and the mixture was extracted with ethyl acetate
(4 × 5 ml). The combined extracts were dried over anhydrous
MgSO4, ﬁltered and evaporated under reduced pressure. Col-
umn chromatography (10% CH3OH in CH2Cl2) gave hydroxy-
acetamide 23 (8 mg, 49%) and Phth-T2-Boc-POM 21 (15 mg,
49%) as a white crystalline solid. Rf 0.46 (10% CH3OH in
CH2Cl2); mp 122–125 C (from CH3OH–CH2Cl2); [α]D 70.83
(c = 0.12, CH3OH); νmax (CHCl3)/cm1 3690, 3410, 3024, 1780
(Phth CO), 1700 (CO); δH (400 MHz, CD3OD) 1.37 (9H, s,
‡ As a consequence of 81Br.
§ As a consequence of 79Br.
C(CH3)3), 1.71 and 1.75 (both 3H, s, thymine CH3), 1.83–1.93
(1H, m, Ha3), 2.09–2.25 (1H, m, Hb3), 2.36–2.46 (2H, m,
H3), 2.60 (1H, dd, J 11.1, 6.1, H5), 2.86–2.94 (2H, m, 2 ×
H2), 3.19–3.27 (1H, m, H5), 3.33 (1H, t, J 9.9, H5), 3.47–3.54
(2H, m, CH2CONH), 3.71 (1H, dd, J 14.4, 2.3, Phth-CHaHb),
3.81 (1H, dd, J 14.6, 4.8, Phth-CHaHb), 3.85 (1H, dd, J 10.6,
3.5, CONHCHaHb), 3.89 (1H, s, H5), 3.92–3.99 (1H, m,
CONHCHaHb), 4.59–4.66 and 4.69–4.74 (each 1H, m, H4),
7.45 (1H, s, H6), 7.67 (4H, br, Ar), 7.70 (1H, s, H6); δC (100.6
MHz, CD3OD) 12.9 (2 × thymine CH3, coincident), 29.2
(C(CH3)3), 34.2 and 37.6 (2 × C3), 40.3 (Phth-CH2), 43.3
(CH2CONH), 50.0 (C5), 55.5 (C2), 57.6 (C4), 57.9 (C5),
59.1 (C4), 64.0 (C2), 82.1 (C (CH3)3), 111.4 and 112.0 (2 ×
C5), 124.7, 133.5 and 136.1 (Ar), 140.3 and 140.6 (2 × C6),
153.2 and 153.3 (2 × C2), 156.8 (Boc CO), 166.5 and 166.6 (2 ×
C4), 170.8 (Phth CO), 173.8 (CH2CONH); m/z (FAB
) 741 ([M
 Na], 9%), 447 ([M  H], 10), 719 ([M  H], 100), 619
(24), 460 (86); HRMS m/z (FAB) 719.3176 ([M  H],
C35H43N8O9 requires m/z, 719.3153).
N-tert-Butoxycarbonyl-(2R,4R )-2-[(hydroxyacetamido)-
methyl]-4-(thymin-1-yl)pyrrolidine (23). δH (400 MHz, CD3OD)
1.40 (9H, s, C(CH3)3), 1.80 (3H, d, J 1.3, thymine CH3), 1.95–
2.09 (1H, m, Ha3), 2.28–2.39 (1H, m, Hb3), 3.26–3.32 (1H, m,
Ha5), 3.48 (2H, br s, NHCH2), 3.86 (1H, dd, J 10.9, 8.1, Hb5),
3.90 (2H, s, CH2OH), 3.93–3.98 (1H, m, H2), 4.72 (1H, m,
H4), 7.39 (1H, d, J 1.0, H6), 8.07 (1H, br s, CH2CONH ); δC
(100.6 MHz, CD3OD) 12.8 (thymine CH3), 29.1 (C(CH3)3),
34.1 (C3), 43.4 (C5), 43.6 (Phth-CH2), 55.2 (C4), 57.4 (C2),
63.1 (CH2OH), 82.3 (C (CH3)3), 112.2 (C5), 139.9 (C6), 153.3
(C2), 156.8 (Boc CO), 166.7 (C4), 176.1 and 176.1 (CH2CONH
rotamers); m/z (FAB) 383 ([M  H], 12%), 283 (100); HRMS
m/z (CI) 383.1934 ([M  H], C17H27N4O6 requires m/z,
383.1930).
Phth-T2-Boc-POM (21) via optimised N-alkylation. DIPEA
(0.33 mL, 1.89 mmol) was added to a solution of amine 19 (300
mg, 0.63 mmol) and bromoacetamide 20 (280 mg, 0.63 mmol)
in dry DMF (2 mL) and the mixture stirred under argon at
room temperature for 18 h. Evaporation under reduced pres-
sure gave a residue to which was added brine (10 mL). The
mixture was extracted with CH2Cl2 (4 × 10 mL), dried over
anhydrous MgSO4, ﬁltered, evaporated and then puriﬁed by
column chromatography (10% CH3OH in CH2Cl2) to give
Phth-T2-Boc-POM 21 (440 mg, 98%) as a white crystalline
solid.
Phth-T2-Boc-POM (21) via N-acylation. Amine 14 (18 mg,
0.056 mmol) was added to a solution of pentaﬂuorophenyl
ester 26 vide infra (32 mg, 0.056 mmol) in CH2Cl2 (2 mL) and
the mixture stirred at room temperature for 3 h. Evaporation
under reduced pressure and puriﬁcation by column chromato-
graphy (5 10% CH3OH in CH2Cl2) gave Phth-T2-Boc-POM
21 (40 mg, 100%) as a white crystalline solid.
(2R,4R )-N-[(tert-Butoxycarbonyl)methyl]-2-[(phthal-
imido)methyl]-4-(thymin-1-yl)pyrrolidine (24). DIPEA (74 µL,
0.428 mmol) and then tert-butyl bromoacetate (35 µL, 0.214
mmol) was added to a solution of amine 19 (50 mg, 0.141
mmol) in dry DMF (0.5 mL) at 0 C. After 5 min the reaction
was warmed to room temperature and stirred for a further 18 h.
Evaporation under reduced pressure followed by column
chromatography (10% CH3OH in CH2Cl2) gave the ester 24 (46
mg, 92%) as a white powder, mp 80–82 C (from CH3OH–
CH2Cl2); [α]D 9.56 (c = 0.46, CH2Cl2); νmax (CHCl3)/cm1
3690, 1770 (Pht CO), 1734, 1715, 1698 and 1684 (CO); δH (300
MHz, CDCl3) 1.34 (3H, s, thymine CH3), 1.42 (9H, s, C(CH3)3),
1.80–1.93 (1H, m, Ha3), 2.43–2.57 (1H, m, Hb3), 2.61–2.73
(1H, m, Ha5), 2.90–2.96 (1H, m, H2), 3.01 (1H, d, J 17.0,
CHaHbCO2
tBu), 3.29 (1H, d, J 10.4, Hb5), 3.72–3.79 (2H, m,
3288 O r g .  B i o m o l .  C h e m . , 2 0 0 3 , 1,  3 2 7 7 – 3 2 9 2
Phth-CH2), 3.83 (1H, d, J 17.0, CHaHbCO2
tBu), 4.78–4.88 (1H,
m, H4), 7.62–7.70 and 7.71–7.79 (each 2H, m, Ar), 7.81 (1H, s,
H6), 8.97 (1H, s, thymine NH); δC (67.9 MHz, CDCl3) 12.0
(thymine CH3), 28.1 (C(CH3)3), 37.0 (C3), 39.0 (Phth-CH2),
52.4 (C4), 54.0 (CH2CO2
tBu), 57.8 (C5), 61.2 (C2), 81.3
(C (CH3)3), 110.6 (C5), 123.3, 131.8 and 134.2 (3 × Ar), 137.9
(C6), 150.9 (C2), 163.5 (C4), 168.4 (Phth CO) and 169.6
(CO2
tBu); m/z (FAB) 469 ([M  H], 25%), 413 (44), 314
(100), 254 (85); HRMS m/z (FAB) 469.2103 ([M  H],
C24H29N4O6 requires m/z, 469.2087).
N-Carboxymethyl-(2R,4R )-2-[(phthalimido)methyl]-4-
(thymin-1-yl)pyrrolidine triﬂuoroacetic acid salt (25). Tri-
ﬂuoroacetic acid (0.5 mL) was added to a solution of tert-butyl
ester 24 (72 mg, 0.154 mmol) in dichloromethane (2.0 mL) and
the mixture was stirred for 3 h at room temperature. Evapor-
ation under reduced pressure followed by column chromato-
graphy (5 15% CH3OH in CH2Cl2) gave the acid 25 (81 mg,
100%) as a white foam. Rf 0.62 (20% CH3OH in CH2Cl2); [α]D
9.0 (c = 0.5, CH3OH); δH (300 MHz, CD3OD) 1.90–2.10 (1H,
m, Ha3), 2.42–2.55 (1H, m, Hb3), 2.60–2.76 (1H, m, Ha5),
2.93–3.15 (1H, m, H2), 3.04 (1H, d, J 17.0, CHaHbCO2H),
3.50–3.60 (1H, m, Hb5), 3.65–3.75 (1H, m, Phth-CHaHb), 3.85
(1H, dd, J 14.7, 4.9, Phth-CHaHb), 3.96 (1H, d, J 17.0, CHaHb-
CO2H), 4.48–4.57 (1H, m, H4), 7.67 (4H, s, Ar), 7.95 (1H, s,
H6); δC (75.5 MHz, CD3OD) 12.5 (thymine CH3), 37.6 (C3),
39.6 (Phth-CH2), 56.0 (CH2CO2H), 56.2 (C4), 58.5 (C5), 63.6
(C2), 111.2 (C5), 117.0 (q, J 244.1, CF3), 124.6, 133.6 and
135.9 (Ar), 141.5 (C6), 153.4 (C2), 163.1 (q, J 88.6, CF3CO2),
166.6 (C4), 170.6 (Phth CO), 176.7 (CO2H); m/z (FAB
) 545
([M  Cs], 6%), 435 ([M  Na], 10), 423 ([M  H], 24), 392
(20), 344 (100); HRMS m/z (FAB) 413.1443 ([M  H],
C20H21N4O6 requires m/z, 413.1461).
N-(Pentaﬂuorophenoxycarbonyl)methyl-(2R,4R )-2-
[(phthalimido)methyl]-4-(thymin-1-yl)pyrrolidine (26). Dry
pyridine (5 µL, 0.063 mmol) and pentaﬂuorophenyl tri-
ﬂuoroacetate (6 µL, 0.035 mmol) were added to a solution of
acid 25 (15 mg, 0.029 mmol) in dry DMF (100 µL). The mixture
was stirred at room temperature for 2 h and then evaporated
under reduced pressure. Ethyl acetate (2 mL) and 5% aqueous
NaHCO3 (2 mL) were then added and the mixture was
extracted with ethyl acetate (5 × 1 mL). The extracts were dried
over anhydrous MgSO4, ﬁltered, evaporated under reduced
pressure and then puriﬁed by column chromatography (ethyl
acetate) to give the ester 26 (13 mg, 78%) as a white foam.
δH (300 MHz, CDCl3) 1.17 (3H, s, thymine CH3), 1.88–1.99
(1H, m, Ha3), 2.54–2.68 (1H, m, Hb3), 2.77 (1H, dd, J 11.3,
6.8, Ha5), 3.00–3.09 (1H, m, H2), 3.30 (1H, d, J 10.9, Hb5),
3.52 (1H, d, J 17.7, NCHaHbCO2), 3.80 (1H, dd, J 14.7, 1.9,
Phth-CHaHb), 3.90 (1H, dd, J 14.7, 4.5, Phth-CHaHb), 4.43
(1H, d, J 17.7, NCHaHbCO2), 4.83–4.92 (1H, m, H4), 7.61
(1H, d, J 1.14, H6), 7.68 (2H, dd, J 5.6, 3.03, Ar), 7.77 (2H, dd,
J 5.5, 3.03, Ar), 7.95 (1H, s, thymine NH); δF (188.2 MHz,
CDCl3) 84.04 (2F, dd, J 21.8, 17.3, m-F), 79.47 (1F, t, J 21.8,
p-F), 74.45 (2F, d, J 17.3, o-F); m/z (FAB) 579 ([M  H],
100%), 292 (73); HRMS m/z (EI) 578.1217 (M, C26H19N4O6F5
requires m/z, 578.1225).
(7R,8aR)-7-(Thymin-1-yl)hexahydropyrrolo[1,2-a]pyrazin-3-
one (28). A solution of Phth-T2-Boc-POM 21 (71 mg, 0.099
mmol) in 40% (w/v) aqueous methylamine (1 mL) was warmed
to 50 C for 5 h. On cooling to room temperature the solution
was evaporated under reduced pressure and puriﬁed by column
chromatography (10 15% CH3OH in CH2Cl2) to give the
lactam 28 (18 mg, 69%) as a white foam. δH (300 MHz, CDCl3)
1.33–1.44 (1H, m, Ha3), 1.89 (3H, d, J 1.1, thymine CH3), 2.40–
2.68 (3H, m, Hb3, H2 and Ha5), 2.86 (1H, d, J 16.2, NCHa-
HbCO), 3.03 (1H, d, J 11.3, Hb5), 3.23 (1H, dd, J 10.6 and 10.9,
NHCHaHb), 3.38–3.47 (1H, m, NHCHaHb), 3.65 (1H, d, J 16.2,
NCHaHbCO), 5.30 (1H, m, H4), 6.78 (1H, br s, CH2CONH ),
7.48 (1H, d, J 1.5, H6); δC (75.5 MHz, CDCl3) 13.1 (thymine
CH3), 37.0 (C3), 46.8 (NHCH2), 52.5 (C4), 56.4 (NCH2), 59.1
(C2), 60.3 (C5), 112.7 (C5), 137.1 (C6), 151.4 (C2), 164.2 (C4),
169.5 (CH2CONH); m/z (FAB
) 265 ([M  H], 100%), 176
(20); HRMS m/z (EI) 264.1225 (M, C12H16N4O3 requires m/z,
264.1222).
T2-Boc-POM (27)
A solution of Phth-T2-Boc-POM 21 (83 mg, 0.116 mmol) in
40% aqueous methylamine (1 mL) was stirred at room temper-
ature for 40 min. Evaporation under reduced pressure then col-
umn chromatography (10 15% CH3OH in CH2Cl2with 0.5%
DIPEA) separated the desired amine 27 at lower Rf from the
intermediate product at higher Rf (assumed to be 29). The latter
29 was treated with 40% aqueous methylamine (1 mL) for a
further 30 min; evaporation and puriﬁcation as before gave
H2N-T2-Boc-POM 27 as a white foam (combined yield of 51
mg, 75%). δH (300 MHz, CD3OD) 1.50 (9H, br s, C(CH3)3), 1.90
and 1.91 (each 3H, s, thymine CH3), 2.27–2.65 (4H, m), 2.73–
2.94 (2H, m), 2.94–3.18 (3H, m), 3.19–3.34 (1H, m), 3.44–3.79
(4H, m), 3.85–4.15 (2H, m), 4.63–4.82 and 4.96–5.11 (each 1H,
m, H4), 7.48 and 7.83 (each 1H, s, H6); δC (75 MHz, CD3OD)
12.7 and 12.9 (2 × thymine CH3), 24.4 (C3), 29.1 (C(CH3)3),
33.5, 36.3, 41.6, 43.5, 45.4, 54.4, 57.6, 57.8, 60.0, 64.2 (2 × C1,
2 × C2, C3, 2 × C4, 2 × C5 and NCH2CONH), 82.2 and
82.5 (C (CH3)3 rotamers), 112.0 and 112.4 (2 × C5), 140.1 and
140.4 (2 × C6), 153.2 and 153.3 (2 × C2), 166.8 and 166.8 (2 ×
C4), 174.2 (CH2CONH); m/z (FAB
) 627 ([M  K], 3%), 511
(5), 345 (60); HRMS m/z (FAB) 627.2893 ([M  K],
C27H40N8O7K requires m/z, 627.2657).
T2-POM3HCl (30)
T2-Boc-POM 27 (51 mg, 0.087 mmol) was dissolved in a solu-
tion of 1 : 1 THF–CH3OH (1 mL) saturated with HCl gas.
After stirring for 15 minutes a white precipitate formed. The
mixture was then cooled to 0 C for 10 min and ﬁltered. The
ﬁltrate was re-cooled to 0 C and a second batch of precipitate
was collected. The combined precipitate was dried under
reduced presure to give T2-POM hydrochloride salt 30 (49 mg,
94%) as a white solid. δH (500 MHz, D2O) 1.88 (3H, s, thymine
CH3), 2.00 (3H, s, thymine* CH3), 2.19 (1H, ddd, J 14.0, 9.9,
6.2, H3), 2.26 (1H, ddd, J 14.3, 11.5, 6.5, H*3), 2.77 (1H, ddd,
J 14.3, 9.6, 7.4, H*3), 2.93 (1H, ddd, J 14.0, 9.6, 7.4, H3), 3.38
(1H, dd, J 13.6, 7.8, H6), 3.47 (1H, dd, J 12.5, 8.8, H5), 3.51
(2H, dd, J 13.6, 3.4, H6), 3.70 (1H, dd, J 13.4, 7.8, H*5), 3.79
(1H, d, J 16.1, H7), 3.81 (1H, dd, J 13.4, 2.8, H*5), 3.86 (2H,
dd, J 15.3, 4.1, H*6 and H*6), 3.91 (1H, dd, J 12.5, 3.7, H5),
3.93 (1H, dddd, J 11.1, 7.4, 41, 4.1, H*2), 4.11 (1H, d, J 16.1,
H7), 4.86 (1H, dddd, J 9.6, 7.8, 6.5, 2.8, H*4), 5.03 (1H, dddd,
J 9.6, 8.8, 6.2, 3.7, H4), 7.48 (1H, s, H*6), 7.61 (1H, s, H6).
*Denotes lower pyrrolidine ring (see ESI for numbering sys-
tem). δC (100.6 MHz, D2O) 11.6 and 11.7 (2 × thymine CH3),
31.6 and 33.4 (2 × C3), 39.1 and 39.3 (2 × C5), 49.5, 55.1, 59.3
(2 × C6, NCH2CO), 57.1, 60.1, 60.8, 63.3 (2 × C2, 2 × C4),
110.8 and 111.5 (2 × C5), 142.1 and 143.5 (2 × C6), 152.3 and
152.7 (2 × C2), 166.8 and 167.0 (2 × C4), 171.5 (CH2CONH);
m/z (FAB) 511 ([M  3HCl  Na], 98%), 489 ([M  3HCl 
H], 100); HRMS m/z (FAB) 489.2565 ([M  3HCl  H],
C22H33N8O5 requires m/z, 489.2574).
Phth-T3-Boc-POM (32)
Phth-T2-Boc-POM 21 (370 mg, 0.515 mmol) was added to a
20% solution of CF3CO2H in CH2Cl2 (10 mL) and stirred at
room temperature for 4 h. The solvent was removed under a
stream of argon followed by evaporation under reduced pres-
sure. Dry DMF (2 mL), bromoacetamide 20 (229 mg, 0.515
mmol) and DIPEA (450 µL, 2.58 mmol) were then added and
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the solution stirred at room temperature for 16 h. Evaporation
under reduced pressure and puriﬁcation by column chromato-
graphy (10 20% CH3OH in CH2Cl2) gave Phth-T3-Boc-POM
32 (0.490 g, 97%) as a white solid. Rf 0.27 (9% CH3OH and 1%
Et3N in CH2Cl2); δH (300 MHz, CD3OD) 1.21 (3H, s, thymine
CH3), 1.51 (9H, s, C(CH3)3), 1.87 and 1.98 (each 3H, s, thymine
CH3), 1.98–3.20 (12H, m), 3.30–4.40 (13H, m), 4.58–4.67, 4.67–
4.82 and 4.97–5.08 (each 1H, m, CH4), 7.51 (1H, s, H6), 7.73–
7.79 (4H, m, Ar), 8.07 and 8.09 (each 1H, s, H6); δC (75.5 MHz,
CD3OD) 12.5, 12.8 and 13.2 (3 × thymine CH3), 33.9, 36.5,
37.6, 39.6, 43.4, 43.5, 54.3, 55.2, 55.7, 56.6, 57.5, 57.9, 58.5,
60.2, 63.0, 63.6 and 65.3 (3 × C2, 3 × C3, 3 × C4, 3 × C5, 2 ×
CONHCH2, Phth-CH2 and 2 × NCH2CONH), 82.2 (C (CH3)),
111.0, 111.8 and 112.0 (3 × C5), 124.7, 133.7, 133.5 and 135.9
(Ar C), 140.8, 141.0 and 141.1 (3 × C6), 153.1, 153.2 and 153.6
(3 × C2), 156.7 (Boc CO), 166.5, 166.7 and 167.2 (3 × C4),
170.5 (Phth CO), 173.6 and 174.2 (2 × CH2CONH);
m/z (FAB) 1005 ([M  Na], 50%), 983 ([M  H], 100), 883
(42), 466 (48); HRMS m/z (FAB) 983.4334 ([M  H],
C47H59N12O12 requires m/z, 983.4375).
Phth-T4-Boc-POM (33)
Phth-T3-Boc-POM 32 (410 mg, 0.418 mmol) was added to a
20% solution of CF3CO2H in CH2Cl2 (10 mL) and the solution
stirred at room temperature for 4 h. The solvent was removed
under a stream of argon followed by evaporation under reduced
pressure. Dry DMF (2 mL), bromoacetamide 20 (185 mg, 0.418
mmol) and then DIPEA (440 µL, 2.53 mmol) were added and
the solution stirred at room temperature for 16 h. Evaporation
under reduced pressure and then puriﬁcation by column chro-
matography (15% CH3OH in CH2Cl2) gave Phth-T4-Boc-POM
33 (500 mg, 96%) as a white solid. δH (400 MHz, CD3OD) 1.08,
1.76, 1.83 and 1.85 (each 3H, s, thymine CH3), 1.38 (9H, s,
C(CH3)3), 1.55–1.64 and 1.78–1.82 (each 1H, m, Ha3), 1.87–
1.95 (2H, m, 2 × Ha3), 1.99–4.0 (30H, 3 × NHCH2CH2, Phth-
CH2, 4 × H2, 4 × Hb3, 4 × H5 and 3 × NCH2CONH), 4.48–
4.54 (1H, m, Ha4), 4.54–4.68 (1H, m, Hb4), 4.85–4.93 (1H, m,
HA4), 4.75–4.85 (probably 1H, HB4 masked by residual
HDO), 7.36, 7.87, 7.92 and 8.00 (each 1H, s, H6), 7.64 and 7.65
(each 2H, s, Ar); δC (100.6 MHz, CD3OD) 12.6, 12.8, 13.3 and
13.3 (4 × thymine CH3), 29.2 (C(CH3)3), 33.7, 36.39, 37.4, 37.6,
38.8, 39.5, 54.3, 54.6, 55.2, 55.6, 56.2, 56.6, 56.9, 57.6, 57.8,
58.4, 59.8, 59.9, 63.6, 64.9 and 65.4 (4 × C2, 4 × C3, 4 × C4, 4
× C5, 3 × CONHCH2, Phth-CH2 and 3 × NCH2CONH)¶,
82.15 (C (CH3)3), 111.0, 111.6, 111.8 and 111.9 (4 × C5), 124.7,
133.5 and 136.0 (3 × Ar), 140.8, 140.9¶ and 141.1 (4 × C6),
153.1, 153.2, 153.3 and 153.6 (4 × C2), 156.7 (Boc CO), 166.4,
166.7, 166.8 and 167.3 (4 × C4), 170.52 (Phth CO), 173.5, 174.1
and 174.2 (3 × CH2CONH); MS m/z (ESI
) 1247.4 ([M  H],
C59H75N16O15 requires m/z, 1247.6).
Phth-T5-Boc-POM (34)
Phth-T4-Boc-POM 33 (240 mg, 0.193 mmol) was added to a
30% solution of CF3CO2H in CH2Cl2 (6 mL) and stirred at
room temperature for 4 h. The solvent was removed under a
stream of argon followed by evaporation under reduced pres-
sure. Dry DMF (4 mL), bromoacetamide 20 (94 mg, 0.21
mmol) and then DIPEA (235 µL, 1.35 mmol) were added and
the solution stirred at room temperature for 16 h. Evaporation
under reduced pressure and puriﬁcation by column chromato-
graphy (10 20% CH3OH in CH2Cl2 then 10 20% CH3OH in
CH2Cl2 with 0.5% DIPEA), gave Phth-T5-Boc-POM 34 (271
mg, ca. 91%) as a white solid containing some residual DIPEA–
TFA salt. Repeated recrystallisation via slow cooling from a
warm saturated methanolic solution aﬀorded an analytically
pure sample. δH (300 MHz, DMSO-d6) 1.32, 1.73 and 1.75
¶ Probably two signals are coincident.
(each 3H, s, 3 × thymine CH3), 1.77 (6H, s, 2 × thymine CH3),
1.40 (9H, s, C(CH3)3), 1.45–1.60 (3H, m, 3 × Ha3), 1.92–2.08
(2H, m, 2 × H3), 2.20–3.90 (38H, 4 × NHCH2CH2, Phth-
CH2, 5 × H2, 5 × H3, 5 × H5 and 4 × NCH2CONH), 4.60–
4.95 (5H, m, 5 × H4), 7.54–8.05 (13H, 5 × H6, 4 × Ar and 4 ×
CH2CONH ), 11.05, 11.12, || 11.17 and 11.28 (5H, 5 × thymine
NH); m/z (ESI) 1511.7 ([M  H], C71H91N20O18 requires m/z,
1511.7).
Phth-T5-POM5HCl (35)
Phth-T5-Boc-POM 34 (7 mg, 4.6 µmol) was treated with a 1 : 1
CH3OH–H2O mixture saturated with HCl gas (2 mL). The
reaction was stirred at 40 C for 5 min and then at room tem-
perature for 2 h. The methanol was then removed under
reduced pressure and the remaining water was lyophilised to
give the desired Phth-T5-POM 35 HCl salt (7 mg, 95%) as a
white powder. A sample was subsequently lyophilised twice
from D2O for NMR purposes. δH (400 MHz, D2O) 1.57, 1.65,
1.72, 1.75 and 1.78 (total 15H, 5 × thymine CH3), 2.00–4.40
(43H, 4 × NHCH2CH2, 1 × Phth-CH2, 5 × H2, 5 × H3, 5 ×
H5 and 4 × NCH2CONH), 4.38–4.67 (5H, m, 5 × H4), 7.33–
7.55 (5H, m, 5 × H6), 7.81 and 7.82 (total 4H, 2 × s, Ar); m/z
(ESI) 706.3 ([M  3H  5Cl]2, C66H84N20O16 requires m/z,
706.3) and 471.2 ([M  2H  5Cl]3, C66H85N20O16 requires
m/z, 471.2).
UV hybridisation studies
General. A Varian-Cary 1 UV-Visible spectrophotometer
equipped with Peltier heating block and six cell transport
mechanism was employed. Quartz cuvettes (24 × 5 × 10 mm)
ﬁtted with Teﬂon stoppers were used throughout. Reference
cuvettes always contained the same buﬀer used in the corre-
sponding sample cuvette. Data were analysed using software
provided by Varian-Cary. For thermal denaturation experi-
ments, absorbance readings were recorded at 260 nm (unless
stated otherwise) with data collection every 0.1 C and an aver-
aging time of 1 s. Temperature monitoring was via a probe
placed inside a cuvette containing buﬀer and adjacent to the
sample cuvette in the cell holder. Concentrations of all oligo-
nucleotides are expressed in mol/base and for each of the oligo-
nucleotides the concentration was 42 µM in bases, unless stated
otherwise. The concentrations of stock solutions were obtained
via serial dilution and for polynucleotides and d(T)20 these were
determined spectrophotometrically at 80 C using the Beer–
Lambert law and the known extinction coeﬃcients of the corre-
sponding nucleotides [ε/dm3 mol1 cm1 15000 for dA, 15000
for rA, 7600 for rC, 12160 for rG, 10210 for rU and 8500 for
dT]. For Phth-T5-POM 35, the extinction coeﬃcient used was
8920 which represents the sum of the extinction coeﬃcients of
thymine (ε = 8500) plus 1/5 of the extinction coeﬃcient of
phthalimide (ε = 2100) at 260 nm. All stock solutions were
stored at 20 C in between use. All sample vials and pipette
tips were sterile and the H2O used was doubly distilled prior to
use. Silicon oil (Sigma) was used to prevent sample evaporation.
All polynucleotides were commercially available (Sigma) while
the 5-mer Lys-T5-LysNH2-PNA (N-terminal lysine and C-
terminal lysine amide) was purchased from PE/Applied
Biosystems, Warrington, UK.
Sample preparation. Unless stated otherwise, thermal melt
experiments were carried out using equimolar amounts (in
bases) of both oligonucleotides taken from aqueous stock solu-
tions and adding 500 µL of double concentrated buﬀer. Water
was then added to give a total volume of 1 mL and the solution
then mixed gently using a pipette before adding it to the cuvette.
A thin layer of oil was then added and a Teﬂon stopper was
inserted to prevent evaporation.
|| Two peaks are coincident.
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Procedures for thermal denaturation experiments. For thermal
denaturation experiments involving Phth-T5-POM 35 and
poly(rA), an equimolar mixture of the two strands (42 µM each
in bases) was initially heated at 5 C min1 from 25–93 C in
order to completely dissociate the strands. After 1 min at 93 C,
the sample was cooled at 0.2 C min1 to 15 C and then after a
further 1 min the sample was heated at 0.2 C min1 to 93 C.
For thermal melting experiments involving Phth-T5-POM 35
and poly(dA), an equimolar mixture of the two strands was
incubated at a concentration of 210 µM each (in bases) at 25 C
for at least 48 h. The sample was then diluted with the
appropriate buﬀer to 1 mL to give a concentration of 42 µM
each (in bases). After cooling from 25 15 C at 1 C min1, the
sample was allowed to equilibrate at 15 C for at least 1 min
and then heated and cooled between 15 and 93 C at 0.2 C
min1. For thermal melting experiments involving d(T)20 or
Lys-T5-LysNH2-PNA with either poly(rA) or poly(dA), a
protocol identical to that used for the Phth-T5-POM
35–poly(rA) thermal melting experiments was followed. For all
Tm determination, the temperature at the maximum of the ﬁrst
derivative of the slow melting curve was used. All melting
experiments were performed at least twice (except where stated
otherwise) and the values shown are the average of these
readings.
Procedures for continuous variation experiments. In order to
determine the stoichiometry for Phth-T5-POM 35 binding to
poly(rA), diﬀerent mole ratios of the two strands at 10% incre-
ments and a total base concentration of 50 µM in 10 mM
K2HPO4 buﬀer adjusted to 0.12 M K
 and pH 7.0, were mixed
by pipette and then allowed to anneal for 24 h at 25 C. The
mixtures were then sequentially transferred into a cuvette and
the UV spectra recorded between 300 and 220 nm.
Procedures for kinetic experiments. Using the Varian-Cary
kinetic software, absorbance changes at 260 nm were monitored
with respect to time at 25 C immediately upon adding and
mixing an equimolar amount of either Phth-T5-POM 35 or
Lys-T5-LysNH2-PNA to a buﬀered solution containing either
poly(rA) or poly(dA). Experiments involving the hybridisation
between Phth-T5-POM 35 and poly(rA) were conducted
using equimolar mixtures of each strand at base concentrations
of 42 µM using a cuvette of path length 1.0 cm. Experiments
involving the hybridisation between Phth-T5-POM 35 and
poly(dA) were conducted using equimolar mixtures of each
strand at base concentrations of either 42 µM or 210 µM (as
indicated) and using cuvettes of path length 1.0 cm or 0.2 cm
respectively.
SPR hybridisation studies. The SPR measurements were per-
formed using a BIAcore 2000 instrument (Biacore AB, UK).
Streptavidin derivatised carboxymethyl dextran sensor chips
(SA) were used as obtained from Biacore. Each sensor chip
contained four ﬂow cells (2.4 × 0.5 × 0.05 mm) with a probing
spot for the SPR signal of ca. 0.26 mm2 for each ﬂow cell.
Buﬀers used were as for UV melting experiments (0.12 M K,
pH 5.0, 6.0 or 7.0, and 1.2 M K, pH 7.0) and were degassed
immediately prior to use. Milli-Q grade water was used
throughout. All assays were carried out at 25 C with data
points collected every 0.5 s. Absence of stem loops or dimers in
the biotinylated mixed sequence oligonucleotides was con-
ﬁrmed using the computer programmes AMPLIFY and GCG
respectively. Data were prepared for analysis and presentation
by subtracting the average response recorded 20 s prior to injec-
tion and adjusting the time of injection to zero. Data from ﬂow
cell 1 (underivatised dextran) were subtracted from the corre-
sponding data obtained from the ﬂow cells (2, 3 and 4) that
contained biotinylated oligonucleotides, in order to correct for
bulk refractive index changes and signal drift. All oligonucleo-
tides were biotinylated at the 5-end using multi biotin-III-CE
phosphoramidite and were purchased from Cruachem,
Glasgow, UK.
General procedures for binding studies. Samples were pre-
pared by serial dilution from aqueous stock solutions. All pro-
cedures for binding studies were automated as methods using
repetitive cycles of sample injection and regeneration. Samples
were injected at a ﬂow rate of 20 µL min1 using the KINJECT
command from 7 mm plastic vials that were capped with
pierceable plastic crimp caps. In order to minimise carryover,
samples were injected in order of increasing concentration. For
all injections the running buﬀer was identical to the injection
buﬀer. Regeneration using 10 mM hydrochloric acid (20 µL,
20 µL min1) was performed between each injection.
Immobilisation of biotinylated oligonucleotides. Onto the
second ﬂow cell of a dextran chip containing streptavidin was
injected a solution of ssDNA 5-biotin-d(A)20 at 1 µg mL
1 in
water for 3 min and at 10 µL min1 until 1450 RU were
obtained. In a similar manner, ﬂow cell 3 was derivatised with
1400 RU of ssRNA 5-biotin-r(A)20 and ﬂow cell 4 with 1000
RU of ssDNA 5-biotin-d(AGC TTC AGA GAT CGA TCG
GAG AGA GTA CTG). After at least 100 s of buﬀer wash,
10 µL of 10 mM hydrochloric acid were passed over all the cells.
T5-POM, T5-PNA, d(T)5 and d(T)20—oligonucleotide binding
assays. Serial two-fold dilutions (160–10 µM, 100 µL, 20 µL
min1) of Phth-T5-POM 35 in 10 mM K2HPO4 adjusted to 0.12
M K and pH 7.0, were passed serially over all four ﬂow cells of
the sensor chip. The complex was then washed with buﬀer for 6
min followed by regeneration using 10 mM hydrochloric acid
(20 µL, 20 µL min1). d(T)5 was assayed in an identical manner
using the same concentrations. PNA (Lys-T5-LysNH2) was
assayed in an identical manner except using serial two-fold dilu-
tions of 40–1.25 µM and d(T)20 using 5–0.31 µM dilutions.
Assays were performed at diﬀerent ionic strength and pH (as
indicated) following an identical protocol.
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